(+)-pilocarpine increases expression EXP 6480464 Pilocarpine results in increased expression of CDKN1B mRNA CTD PMID:17971868 (+)-Tetrandrine increases expression ISO CDKN1B (Homo sapiens) 6480464 tetrandrine results in increased expression of CDKN1B protein CTD PMID:30123091 (+)-Tetrandrine multiple interactions ISO CDKN1B (Homo sapiens) 6480464 [sodium arsenite co-treated with tetrandrine] results in increased expression of CDKN1B protein CTD PMID:30123091 (-)-citrinin decreases expression ISO CDKN1B (Homo sapiens) 6480464 Citrinin results in decreased expression of CDKN1B mRNA CTD PMID:30428381 (-)-citrinin multiple interactions ISO CDKN1B (Homo sapiens) 6480464 [Citrinin co-treated with ochratoxin A] results in decreased expression of CDKN1B mRNA and [Citrinin co-treated with ochratoxin A] results in increased expression of CDKN1B mRNA CTD PMID:30428381 (-)-epigallocatechin 3-gallate multiple interactions ISO CDKN1B (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of CDKN1B mRNA CTD PMID:22079256 (S)-(-)-perillyl alcohol increases expression ISO CDKN1B (Homo sapiens) 6480464 perillyl alcohol results in increased expression of CDKN1B protein CTD PMID:17138864 (S)-(-)-perillyl alcohol increases response to substance ISO CDKN1B (Homo sapiens) 6480464 CDKN1B protein results in increased susceptibility to perillyl alcohol CTD PMID:17138864 (S)-(-)-perillyl alcohol multiple interactions ISO CDKN1B (Homo sapiens) 6480464 perillyl alcohol promotes the reaction [CDKN1B protein binds to and results in decreased activity of CDK2 protein] CTD PMID:17138864 (S)-nicotine multiple interactions ISO CDKN1B (Homo sapiens) 6480464 4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide inhibits the reaction [Nicotine results in decreased expression of CDKN1B protein] and Nicotine results in increased expression of and results in increased stability of CDKN1B protein CTD PMID:15231866 and PMID:18805435 (S)-nicotine decreases expression ISO CDKN1B (Homo sapiens) 6480464 Nicotine results in decreased expression of CDKN1B protein CTD PMID:18805435 (Z)-3-butylidenephthalide increases expression EXP 6480464 butylidenephthalide results in increased expression of CDKN1B protein CTD PMID:16987298 1,2-dimethylhydrazine decreases expression EXP 6480464 1 and 2-Dimethylhydrazine results in decreased expression of CDKN1B mRNA CTD PMID:32387197 1,2-dimethylhydrazine multiple interactions ISO Cdkn1b (Mus musculus) 6480464 Folic Acid inhibits the reaction [1 and 2-Dimethylhydrazine results in decreased expression of CDKN1B mRNA] CTD PMID:22206623 1,2-dimethylhydrazine decreases expression ISO Cdkn1b (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in decreased expression of CDKN1B mRNA CTD PMID:22206623 1,3-thiazolidine-2,4-dione increases expression ISO CDKN1B (Homo sapiens) 6480464 2 and 4-thiazolidinedione results in increased expression of CDKN1B protein CTD PMID:15916743 1-naphthyl isothiocyanate decreases expression EXP 6480464 1-Naphthylisothiocyanate results in decreased expression of CDKN1B mRNA CTD PMID:20551477 14-Deoxy-11,12-didehydroandrographolide increases expression ISO CDKN1B (Homo sapiens) 6480464 14-deoxy-11 and 12-didehydroandrographolide results in increased expression of CDKN1B mRNA CTD PMID:22101062 15-deoxy-Delta(12,14)-prostaglandin J2 decreases expression ISO CDKN1B (Homo sapiens) 6480464 15-deoxy-delta(12 and 14)-prostaglandin J2 results in decreased expression of CDKN1B protein CTD PMID:15729575 17alpha-ethynylestradiol decreases expression EXP 6480464 Ethinyl Estradiol results in decreased expression of CDKN1B mRNA CTD PMID:17557909 17beta-estradiol increases degradation ISO CDKN1B (Homo sapiens) 6480464 Estradiol results in increased degradation of CDKN1B protein CTD PMID:17283133 17beta-estradiol increases expression ISO CDKN1B (Homo sapiens) 6480464 Estradiol analog results in increased expression of CDKN1B protein CTD PMID:36460128 17beta-estradiol increases phosphorylation ISO CDKN1B (Homo sapiens) 6480464 Estradiol results in increased phosphorylation of CDKN1B protein CTD PMID:23029392 17beta-estradiol decreases expression ISO CDKN1B (Homo sapiens) 6480464 Estradiol results in decreased expression of CDKN1B mRNA CTD PMID:22064387 17beta-estradiol increases expression ISO Cdkn1b (Mus musculus) 6480464 Estradiol results in increased expression of CDKN1B mRNA CTD PMID:17640349 17beta-estradiol affects expression ISO Cdkn1b (Mus musculus) 6480464 Estradiol affects the expression of CDKN1B mRNA CTD PMID:15598610 17beta-estradiol multiple interactions ISO CDKN1B (Homo sapiens) 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Estradiol results in increased degradation of CDKN1B protein] more ... CTD PMID:17283133 more ... 17beta-hydroxy-5alpha-androstan-3-one decreases expression ISO CDKN1B (Homo sapiens) 6480464 Dihydrotestosterone results in decreased expression of CDKN1B mRNA CTD PMID:26804032 17beta-hydroxy-5alpha-androstan-3-one multiple interactions ISO CDKN1B (Homo sapiens) 6480464 Dihydrotestosterone inhibits the reaction [[Curcumin co-treated with Quercetin] results in increased expression of CDKN1B protein] CTD PMID:27132804 2,2',4,4'-Tetrabromodiphenyl ether affects expression ISO CDKN1B (Homo sapiens) 6480464 2 more ... CTD PMID:26988655 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO CDKN1B (Homo sapiens) 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of CDKN1B protein more ... CTD PMID:15157999 more ... 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of CDKN1B mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Cdkn1b (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of CDKN1B mRNA and Tetrachlorodibenzodioxin results in increased expression of CDKN1B protein CTD PMID:10398686 more ... 2,3,7,8-tetrachlorodibenzodioxine affects response to substance ISO Cdkn1b (Mus musculus) 6480464 CDKN1B protein affects the susceptibility to Tetrachlorodibenzodioxin CTD PMID:20805476 2,3,7,8-tetrachlorodibenzodioxine affects localization ISO Cdkn1b (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the localization of CDKN1B protein CTD PMID:20805476 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of CDKN1B mRNA and Tetrachlorodibenzodioxin results in increased expression of CDKN1B protein CTD PMID:14742689 more ... 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO CDKN1B (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in increased expression of CDKN1B protein CTD PMID:15157999 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Cdkn1b (Mus musculus) 6480464 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CDKN1B protein] more ... CTD PMID:12883080 more ... 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:32109520 2-acetamidofluorene multiple interactions EXP 6480464 2-Acetylaminofluorene promotes the reaction [Diethylnitrosamine results in decreased expression of CDKN1B protein] and Pioglitazone inhibits the reaction [2-Acetylaminofluorene promotes the reaction [Diethylnitrosamine results in decreased expression of CDKN1B protein]] CTD PMID:17582756 2-amino-2-deoxy-D-glucopyranose decreases expression EXP 6480464 Glucosamine results in decreased expression of CDKN1B protein CTD PMID:15654767 2-cyclopenten-1-one increases expression ISO CDKN1B (Homo sapiens) 6480464 cyclopentenone results in increased expression of CDKN1B CTD PMID:16061222 2-hydroxypropanoic acid increases expression ISO CDKN1B (Homo sapiens) 6480464 Lactic Acid results in increased expression of CDKN1B mRNA CTD PMID:30851411 2-methoxy-17beta-estradiol increases expression ISO CDKN1B (Homo sapiens) 6480464 2-Methoxyestradiol results in increased expression of CDKN1B protein CTD PMID:23967052 2-methoxyethanol increases expression EXP 6480464 methyl cellosolve results in increased expression of CDKN1B mRNA CTD PMID:19643169 25-hydroxycholesterol increases expression EXP 6480464 25-hydroxycholesterol results in increased expression of CDKN1B mRNA CTD PMID:17161435 3',5'-cyclic AMP multiple interactions EXP 6480464 [Pentoxifylline results in increased abundance of Cyclic AMP] which results in increased expression of CDKN1B protein more ... CTD PMID:21693435 3',5'-cyclic AMP multiple interactions ISO CDKN1B (Homo sapiens) 6480464 [Theophylline results in increased abundance of Cyclic AMP] which results in increased expression of CDKN1B protein CTD PMID:21693435 3,3',5-triiodo-L-thyronine decreases expression EXP 6480464 Triiodothyronine results in decreased expression of CDKN1B mRNA and Triiodothyronine results in decreased expression of CDKN1B protein CTD PMID:16021636 3,3',5-triiodo-L-thyronine decreases expression ISO Cdkn1b (Mus musculus) 6480464 Triiodothyronine results in decreased expression of CDKN1B protein CTD PMID:20638743 3,3',5-triiodo-L-thyronine multiple interactions ISO Cdkn1b (Mus musculus) 6480464 THRB protein promotes the reaction [Triiodothyronine results in decreased expression of CDKN1B protein] CTD PMID:20638743 3,3',5-triiodo-L-thyronine decreases expression ISO CDKN1B (Homo sapiens) 6480464 Triiodothyronine results in decreased expression of CDKN1B protein CTD PMID:16021636 3,3'-diindolylmethane increases expression ISO CDKN1B (Homo sapiens) 6480464 3 and 3'-diindolylmethane results in increased expression of CDKN1B protein CTD PMID:22290291 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO Cdkn1b (Mus musculus) 6480464 5 more ... CTD PMID:24646949 more ... 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO CDKN1B (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CDKN1B mRNA more ... CTD PMID:28628672 3-methylcholanthrene multiple interactions ISO CDKN1B (Homo sapiens) 6480464 Acetylcysteine inhibits the reaction [Methylcholanthrene results in increased expression of CDKN1B protein] and resveratrol inhibits the reaction [Methylcholanthrene results in increased expression of CDKN1B protein] CTD PMID:18022818 3-methylcholanthrene increases response to substance ISO CDKN1B (Homo sapiens) 6480464 CDKN1B protein results in increased susceptibility to Methylcholanthrene CTD PMID:18022818 3-methylcholanthrene increases expression ISO CDKN1B (Homo sapiens) 6480464 Methylcholanthrene results in increased expression of CDKN1B protein CTD PMID:18022818 4,4'-sulfonyldiphenol multiple interactions ISO CDKN1B (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of CDKN1B mRNA CTD PMID:28628672 4,4'-sulfonyldiphenol multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of CDKN1B mRNA CTD PMID:36041667 4,4'-sulfonyldiphenol increases expression ISO CDKN1B (Homo sapiens) 6480464 bisphenol S results in increased expression of CDKN1B protein CTD PMID:30292839 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one decreases expression ISO CDKN1B (Homo sapiens) 6480464 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of CDKN1B protein CTD PMID:18805435 and PMID:30236600 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one multiple interactions ISO CDKN1B (Homo sapiens) 6480464 4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of CDKN1B protein] CTD PMID:18805435 4-\{[(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)carbonyl]amino\}benzoic acid affects localization ISO CDKN1B (Homo sapiens) 6480464 Am 580 affects the localization of CDKN1B protein CTD PMID:16618747 4-hydroxyphenyl retinamide increases expression ISO CDKN1B (Homo sapiens) 6480464 Fenretinide results in increased expression of CDKN1B protein CTD PMID:16270382 4-nitroquinoline N-oxide decreases expression ISO Cdkn1b (Mus musculus) 6480464 4-Nitroquinoline-1-oxide results in decreased expression of CDKN1B mRNA CTD PMID:22561872 4-nonylphenol increases expression EXP 6480464 4-nonylphenol results in increased expression of CDKN1B protein CTD PMID:26804764 4-nonylphenol decreases expression ISO CDKN1B (Homo sapiens) 6480464 4-nonylphenol results in decreased expression of CDKN1B mRNA CTD PMID:26804032 4-tert-Octylphenol increases phosphorylation ISO CDKN1B (Homo sapiens) 6480464 4-tert-octylphenol results in increased phosphorylation of CDKN1B protein CTD PMID:32466334 4-vinylcyclohexene dioxide affects expression ISO Cdkn1b (Mus musculus) 6480464 4-vinyl-1-cyclohexene dioxide affects the expression of CDKN1B mRNA CTD PMID:20829426 5-aza-2'-deoxycytidine multiple interactions ISO CDKN1B (Homo sapiens) 6480464 [Decitabine co-treated with 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one co-treated with Sirolimus] results in increased expression of CDKN1B mRNA and [Decitabine co-treated with trichostatin A] results in increased expression of CDKN1B mRNA CTD PMID:17185465 and PMID:18622747 5-aza-2'-deoxycytidine decreases expression ISO Cdkn1b (Mus musculus) 6480464 Decitabine results in decreased expression of CDKN1B mRNA CTD PMID:27915011 5-aza-2'-deoxycytidine affects expression ISO CDKN1B (Homo sapiens) 6480464 [Decitabine affects the expression of DNMT3B protein] which affects the expression of CDKN1B mRNA CTD PMID:18544619 5-fluorouracil affects response to substance ISO CDKN1B (Homo sapiens) 6480464 CDKN1B protein affects the susceptibility to Fluorouracil CTD PMID:17217824 5-fluorouracil decreases expression ISO CDKN1B (Homo sapiens) 6480464 Fluorouracil results in decreased expression of CDKN1B mRNA CTD PMID:18930000 5-iodotubercidin decreases phosphorylation EXP 6480464 5-iodotubercidin results in decreased phosphorylation of CDKN1B protein CTD PMID:26953159 6-propyl-2-thiouracil decreases expression ISO Cdkn1b (Mus musculus) 6480464 Propylthiouracil results in decreased expression of CDKN1B protein CTD PMID:29578053 9-cis-retinoic acid increases stability ISO CDKN1B (Homo sapiens) 6480464 Alitretinoin results in increased stability of CDKN1B protein CTD PMID:11348869 9-cis-retinoic acid multiple interactions ISO CDKN1B (Homo sapiens) 6480464 Alitretinoin inhibits the reaction [[[PDGFB protein binds to PDGFB protein] which co-treated with INS protein] results in decreased expression of CDKN1B protein] and seocalcitol inhibits the reaction [Alitretinoin results in increased expression of CDKN1B protein] CTD PMID:11348869 and PMID:16340750 9-cis-retinoic acid increases expression ISO CDKN1B (Homo sapiens) 6480464 Alitretinoin results in increased expression of CDKN1B protein CTD PMID:16340750 9-Methoxycamptothecin increases expression ISO CDKN1B (Homo sapiens) 6480464 9-methoxycamptothecin results in increased expression of CDKN1B mRNA and 9-methoxycamptothecin results in increased expression of CDKN1B protein CTD PMID:23369935 acetylsalicylic acid multiple interactions ISO CDKN1B (Homo sapiens) 6480464 [troglitazone co-treated with Aspirin] results in increased expression of CDKN1B protein CTD PMID:19908241 acetylsalicylic acid increases expression ISO Cdkn1b (Mus musculus) 6480464 Aspirin results in increased expression of CDKN1B protein CTD PMID:16880202 acrolein multiple interactions EXP 6480464 [ferric oxide analog co-treated with Acrolein] results in decreased expression of CDKN1B protein CTD PMID:24847785 acrylamide decreases expression ISO CDKN1B (Homo sapiens) 6480464 Acrylamide results in decreased expression of CDKN1B protein CTD PMID:20734998 acrylamide multiple interactions ISO Cdkn1b (Mus musculus) 6480464 [Acrylamide co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CDKN1B protein CTD PMID:30409764 acrylonitrile decreases expression ISO CDKN1B (Homo sapiens) 6480464 Acrylonitrile results in decreased expression of CDKN1B protein CTD PMID:30236600 acrylonitrile increases expression ISO CDKN1B (Homo sapiens) 6480464 Acrylonitrile results in increased expression of CDKN1B protein CTD PMID:33132245 acteoside multiple interactions ISO CDKN1B (Homo sapiens) 6480464 acteoside promotes the reaction [CDKN1B protein binds to CDK4 protein] and acteoside promotes the reaction [CDKN1B protein binds to CDK6 protein] CTD PMID:17634406 acteoside increases expression ISO CDKN1B (Homo sapiens) 6480464 acteoside results in increased expression of CDKN1B mRNA and acteoside results in increased expression of CDKN1B protein CTD PMID:17634406 actinomycin D multiple interactions ISO Cdkn1b (Mus musculus) 6480464 CDKN1B protein affects the reaction [Dactinomycin results in increased degradation of PTGS2 mRNA] CTD PMID:23639288 afimoxifene multiple interactions ISO CDKN1B (Homo sapiens) 6480464 [afimoxifene co-treated with lapatinib] promotes the reaction [CDKN1B protein binds to and results in decreased activity of [CCNE1 protein binds to CDK2 protein]] more ... CTD PMID:15665275 afimoxifene increases expression ISO CDKN1B (Homo sapiens) 6480464 afimoxifene results in increased expression of CDKN1B protein CTD PMID:15665275 afimoxifene increases expression ISO Cdkn1b (Mus musculus) 6480464 afimoxifene results in increased expression of CDKN1B mRNA CTD PMID:17640349 aflatoxin B1 decreases methylation ISO CDKN1B (Homo sapiens) 6480464 Aflatoxin B1 results in decreased methylation of CDKN1B gene CTD PMID:27153756 aflatoxin B1 decreases expression EXP 6480464 Aflatoxin B1 results in decreased expression of CDKN1B mRNA and Aflatoxin B1 results in decreased expression of CDKN1B protein CTD PMID:34015426 aldehydo-D-glucosamine decreases expression EXP 6480464 Glucosamine results in decreased expression of CDKN1B protein CTD PMID:15654767 aldehydo-D-glucose increases expression EXP 6480464 Glucose results in increased expression of CDKN1B protein CTD PMID:22561310 aldehydo-D-glucose increases expression ISO CDKN1B (Homo sapiens) 6480464 Glucose results in increased expression of CDKN1B protein CTD PMID:33992720 aldehydo-D-glucose multiple interactions ISO CDKN1B (Homo sapiens) 6480464 [Glucose co-treated with Deferoxamine] results in increased expression of CDKN1B mRNA and Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of CDKN1B mRNA] CTD PMID:33962019 aldehydo-D-glucose multiple interactions EXP 6480464 NAD inhibits the reaction [Glucose results in increased expression of CDKN1B protein] more ... CTD PMID:22561310 Alisol B increases expression ISO CDKN1B (Homo sapiens) 6480464 alisol B results in increased expression of CDKN1B protein CTD PMID:20197400 all-trans-retinoic acid multiple interactions ISO CDKN1B (Homo sapiens) 6480464 [Tretinoin co-treated with IFNG protein] results in increased expression of CDKN1B protein more ... CTD PMID:11348869 more ... all-trans-retinoic acid increases stability ISO CDKN1B (Homo sapiens) 6480464 Tretinoin results in increased stability of CDKN1B protein CTD PMID:11348869 all-trans-retinoic acid affects expression ISO CDKN1B (Homo sapiens) 6480464 Tretinoin affects the expression of CDKN1B mRNA CTD PMID:21924320 all-trans-retinoic acid increases phosphorylation EXP 6480464 Tretinoin results in increased phosphorylation of CDKN1B protein CTD PMID:16618747 all-trans-retinoic acid affects localization EXP 6480464 Tretinoin affects the localization of CDKN1B protein CTD PMID:16618747 all-trans-retinoic acid increases phosphorylation ISO CDKN1B (Homo sapiens) 6480464 Tretinoin results in increased phosphorylation of CDKN1B protein CTD PMID:16618747 all-trans-retinoic acid increases expression ISO CDKN1B (Homo sapiens) 6480464 Tretinoin results in increased expression of CDKN1B more ... CTD PMID:11519864 more ... all-trans-retinoic acid affects localization ISO CDKN1B (Homo sapiens) 6480464 Tretinoin affects the localization of CDKN1B protein CTD PMID:16618747 allose increases expression ISO CDKN1B (Homo sapiens) 6480464 allose results in increased expression of CDKN1B protein CTD PMID:18930000 Allylamine multiple interactions EXP 6480464 pyrrolidine dithiocarbamic acid inhibits the reaction [Allylamine results in increased expression of CDKN1B protein] CTD PMID:15048878 Allylamine increases expression EXP 6480464 Allylamine results in increased expression of CDKN1B protein CTD PMID:15048878 alpha-naphthoflavone multiple interactions ISO CDKN1B (Homo sapiens) 6480464 alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of CDKN1B protein] and alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CDKN1B protein] CTD PMID:15157999 and PMID:22266097 alvocidib increases cleavage ISO CDKN1B (Homo sapiens) 6480464 alvocidib results in increased cleavage of CDKN1B protein CTD PMID:10537362 alvocidib increases expression ISO CDKN1B (Homo sapiens) 6480464 [alvocidib results in increased expression of TP53 protein] which results in increased expression of CDKN1B protein and alvocidib results in increased expression of CDKN1B protein CTD PMID:12589031 and PMID:15180955 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of CDKN1B mRNA CTD PMID:16483693 anilines increases expression ISO CDKN1B (Homo sapiens) 6480464 Aniline Compounds results in increased expression of CDKN1B protein CTD PMID:25123791 anthocyanin increases expression ISO CDKN1B (Homo sapiens) 6480464 Anthocyanins results in increased expression of CDKN1B protein CTD PMID:27444805 aristolochic acid A decreases expression ISO CDKN1B (Homo sapiens) 6480464 aristolochic acid I results in decreased expression of CDKN1B mRNA CTD PMID:33212167 arotinoid acid increases stability ISO CDKN1B (Homo sapiens) 6480464 4-(2-(5 more ... CTD PMID:11348869 arotinoid acid multiple interactions ISO CDKN1B (Homo sapiens) 6480464 4-(2-(5 more ... CTD PMID:11348869 arsane decreases expression ISO Cdkn1b (Mus musculus) 6480464 Arsenic results in decreased expression of CDKN1B mRNA CTD PMID:19654921 arsane affects methylation ISO CDKN1B (Homo sapiens) 6480464 Arsenic affects the methylation of CDKN1B gene CTD PMID:25304211 arsane multiple interactions ISO CDKN1B (Homo sapiens) 6480464 [silybin co-treated with Arsenic] results in increased expression of CDKN1B protein CTD PMID:25868784 arsenic atom decreases expression ISO Cdkn1b (Mus musculus) 6480464 Arsenic results in decreased expression of CDKN1B mRNA CTD PMID:19654921 arsenic atom affects methylation ISO CDKN1B (Homo sapiens) 6480464 Arsenic affects the methylation of CDKN1B gene CTD PMID:25304211 arsenic atom multiple interactions ISO CDKN1B (Homo sapiens) 6480464 [silybin co-treated with Arsenic] results in increased expression of CDKN1B protein CTD PMID:25868784 arsenite(3-) multiple interactions ISO Cdkn1b (Mus musculus) 6480464 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole affects the reaction [[CDKN1B protein affects the susceptibility to [sodium arsenite results in increased abundance of arsenite]] which affects the expression of PTGS2 protein] more ... CTD PMID:23639288 arsenite(3-) increases methylation ISO CDKN1B (Homo sapiens) 6480464 arsenite results in increased methylation of CDKN1B promoter CTD PMID:23974009 arsenous acid decreases expression ISO CDKN1B (Homo sapiens) 6480464 Arsenic Trioxide results in decreased expression of CDKN1B mRNA CTD PMID:19769630 arsenous acid multiple interactions ISO CDKN1B (Homo sapiens) 6480464 [Arsenic Trioxide co-treated with Curcumin] results in increased expression of CDKN1B protein more ... CTD PMID:20698225 more ... arsenous acid increases expression ISO CDKN1B (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of CDKN1B gene more ... CTD PMID:19236751 more ... aspartame multiple interactions ISO Cdkn1b (Mus musculus) 6480464 [Fats and Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of CDKN1B mRNA CTD PMID:23783067 aspartame decreases expression ISO CDKN1B (Homo sapiens) 6480464 Aspartame results in decreased expression of CDKN1B protein CTD PMID:33992720 atorvastatin calcium multiple interactions ISO CDKN1B (Homo sapiens) 6480464 [Atorvastatin co-treated with Celecoxib] results in increased expression of CDKN1B protein CTD PMID:18172863 atorvastatin calcium increases expression ISO CDKN1B (Homo sapiens) 6480464 Atorvastatin results in increased expression of CDKN1B protein CTD PMID:16470222 atrazine multiple interactions ISO CDKN1B (Homo sapiens) 6480464 [Atrazine co-treated with Arsenates] results in increased expression of CDKN1B mRNA CTD PMID:18585445 benzene decreases expression ISO Cdkn1b (Mus musculus) 6480464 Benzene results in decreased expression of CDKN1B mRNA CTD PMID:20018183 benzo[a]pyrene decreases expression ISO Cdkn1b (Mus musculus) 6480464 Benzo(a)pyrene results in decreased expression of CDKN1B mRNA CTD PMID:22228805 benzo[a]pyrene decreases expression ISO CDKN1B (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased expression of CDKN1B protein CTD PMID:30236600 benzo[a]pyrene affects methylation ISO CDKN1B (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of CDKN1B promoter CTD PMID:27901495 benzo[a]pyrene multiple interactions ISO Cdkn1b (Mus musculus) 6480464 [chromium hexavalent ion co-treated with Benzo(a)pyrene] affects the expression of CDKN1B mRNA more ... CTD PMID:21995607 and PMID:25820237 benzo[a]pyrene increases expression ISO Cdkn1b (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of CDKN1B mRNA CTD PMID:21995607 benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of CDKN1B protein CTD PMID:17141280 benzo[a]pyrene multiple interactions EXP 6480464 AHR affects the reaction [Benzo(a)pyrene results in decreased expression of CDKN1B protein] CTD PMID:17141280 Benzo[ghi]perylene increases expression ISO CDKN1B (Homo sapiens) 6480464 1 more ... CTD PMID:35182551 Benzo[ghi]perylene multiple interactions ISO CDKN1B (Homo sapiens) 6480464 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [1 more ... CTD PMID:35182551 berberine increases expression ISO CDKN1B (Homo sapiens) 6480464 Berberine results in increased expression of CDKN1B protein CTD PMID:16505103 beta-D-glucosamine decreases expression EXP 6480464 Glucosamine results in decreased expression of CDKN1B protein CTD PMID:15654767 beta-hexachlorocyclohexane increases expression ISO Cdkn1b (Mus musculus) 6480464 beta-hexachlorocyclohexane results in increased expression of CDKN1B mRNA CTD PMID:17640349 bicalutamide increases expression ISO CDKN1B (Homo sapiens) 6480464 bicalutamide results in increased expression of CDKN1B CTD PMID:11845989 bis(2-chloroethyl) sulfide decreases expression ISO Cdkn1b (Mus musculus) 6480464 Mustard Gas results in decreased expression of CDKN1B mRNA CTD PMID:15674843 bis(2-ethylhexyl) phthalate multiple interactions ISO Cdkn1b (Mus musculus) 6480464 [diethyl phthalate co-treated with Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisobutyl phthalate co-treated with diisononyl phthalate] results in decreased expression of CDKN1B mRNA CTD PMID:37839492 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of CDKN1B mRNA and bisphenol A results in increased expression of CDKN1B protein CTD PMID:20692330 more ... bisphenol A increases phosphorylation ISO CDKN1B (Homo sapiens) 6480464 bisphenol A results in increased phosphorylation of CDKN1B protein CTD PMID:32466334 bisphenol A decreases expression ISO Cdkn1b (Mus musculus) 6480464 bisphenol A results in decreased expression of CDKN1B mRNA CTD PMID:33221593 bisphenol A increases expression ISO CDKN1B (Homo sapiens) 6480464 bisphenol A results in increased expression of CDKN1B protein CTD PMID:29383186 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of CDKN1B mRNA and [bisphenol A co-treated with tributyltin] results in increased expression of CDKN1B mRNA CTD PMID:31129395 and PMID:36041667 bisphenol A decreases expression ISO CDKN1B (Homo sapiens) 6480464 bisphenol A results in decreased expression of CDKN1B mRNA CTD PMID:27998958 bisphenol A multiple interactions ISO CDKN1B (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of CDKN1B gene and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CDKN1B mRNA CTD PMID:28628672 and PMID:31601247 bisphenol A affects expression ISO CDKN1B (Homo sapiens) 6480464 bisphenol A affects the expression of CDKN1B protein CTD PMID:25130739 bisphenol A increases expression ISO Cdkn1b (Mus musculus) 6480464 bisphenol A results in increased expression of CDKN1B mRNA and bisphenol A results in increased expression of CDKN1B protein CTD PMID:24809654 and PMID:26063408 bisphenol F multiple interactions ISO CDKN1B (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CDKN1B mRNA CTD PMID:28628672 bisphenol F multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of CDKN1B mRNA CTD PMID:36041667 bortezomib multiple interactions ISO CDKN1B (Homo sapiens) 6480464 [Bortezomib co-treated with Butyrates] results in increased cleavage of CDKN1B protein more ... CTD PMID:15173093 more ... bortezomib increases stability ISO CDKN1B (Homo sapiens) 6480464 Bortezomib results in increased stability of CDKN1B protein CTD PMID:15543232 bortezomib increases expression ISO CDKN1B (Homo sapiens) 6480464 Bortezomib results in increased expression of CDKN1B protein CTD PMID:14749476 more ... bosutinib multiple interactions ISO Cdkn1b (Mus musculus) 6480464 Imatinib Mesylate promotes the reaction [bosutinib results in increased expression of CDKN1B protein] CTD PMID:17129604 bosutinib increases expression ISO Cdkn1b (Mus musculus) 6480464 bosutinib results in increased expression of CDKN1B protein CTD PMID:17129604 BQ 123 multiple interactions ISO CDKN1B (Homo sapiens) 6480464 cyclo(Trp-Asp-Pro-Val-Leu) inhibits the reaction [VEGFC protein results in decreased expression of CDKN1B protein] CTD PMID:24184161 brassinolide decreases expression ISO CDKN1B (Homo sapiens) 6480464 brassinolide results in decreased expression of CDKN1B protein CTD PMID:20833159 Brodifacoum decreases expression EXP 6480464 bromfenacoum results in decreased expression of CDKN1B protein CTD PMID:28903499 bucladesine increases expression EXP 6480464 Bucladesine results in increased expression of CDKN1B protein CTD PMID:16718685 and PMID:21693435 budesonide multiple interactions ISO Cdkn1b (Mus musculus) 6480464 Budesonide inhibits the reaction [vinyl carbamate results in decreased expression of CDKN1B protein] CTD PMID:12117777 Butylbenzyl phthalate multiple interactions ISO Cdkn1b (Mus musculus) 6480464 [diethyl phthalate co-treated with Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisobutyl phthalate co-treated with diisononyl phthalate] results in decreased expression of CDKN1B mRNA CTD PMID:37839492 cadmium atom increases expression EXP 6480464 Cadmium results in increased expression of CDKN1B protein CTD PMID:16730872 cadmium atom multiple interactions ISO CDKN1B (Homo sapiens) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CDKN1B protein and GJA1 protein affects the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CDKN1B protein] CTD PMID:28176351 cadmium atom decreases expression EXP 6480464 Cadmium results in decreased expression of CDKN1B protein CTD PMID:27658547 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of CDKN1B protein CTD PMID:16730872 cadmium dichloride increases expression ISO CDKN1B (Homo sapiens) 6480464 Cadmium Chloride results in increased expression of CDKN1B mRNA CTD PMID:32512071 and PMID:33129824 cadmium dichloride multiple interactions ISO CDKN1B (Homo sapiens) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CDKN1B protein and GJA1 protein affects the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CDKN1B protein] CTD PMID:28176351 cadmium dichloride decreases expression ISO CDKN1B (Homo sapiens) 6480464 Cadmium Chloride results in decreased expression of CDKN1B protein CTD PMID:27510461 cadmium dichloride multiple interactions ISO Cdkn1b (Mus musculus) 6480464 Cadmium Chloride inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of CDKN1B protein] and Cadmium Chloride promotes the reaction [Methylnitronitrosoguanidine results in decreased expression of CDKN1B mRNA] CTD PMID:11516527 and PMID:12135628 cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of CDKN1B mRNA CTD PMID:18636176 calciol multiple interactions ISO CDKN1B (Homo sapiens) 6480464 Cholecalciferol promotes the reaction [CDKN1B protein binds to CDK2 protein] and Cholecalciferol results in increased expression of and results in decreased degradation of CDKN1B protein CTD PMID:12907249 calciol increases expression ISO CDKN1B (Homo sapiens) 6480464 Cholecalciferol results in increased expression of CDKN1B mRNA CTD PMID:12907249 calcitriol multiple interactions ISO CDKN1B (Homo sapiens) 6480464 Calcitriol promotes the reaction [CDKN1B protein binds to CDK4 protein] and Calcitriol results in decreased phosphorylation of and results in decreased degradation of and results in increased stability of CDKN1B protein CTD PMID:12954644 and PMID:16322758 calcitriol increases expression ISO CDKN1B (Homo sapiens) 6480464 Calcitriol results in increased expression of CDKN1B more ... CTD PMID:10825140 more ... calcium dichloride multiple interactions EXP 6480464 Calcium Chloride inhibits the reaction [Azoxymethane results in decreased expression of CDKN1B protein] CTD PMID:12189186 Calpeptin decreases expression ISO Cdkn1b (Mus musculus) 6480464 calpeptin results in decreased expression of CDKN1B protein modified form CTD PMID:22432027 capsaicin decreases expression ISO CDKN1B (Homo sapiens) 6480464 Capsaicin results in decreased expression of CDKN1B protein CTD PMID:22226932 capsaicin increases expression ISO Cdkn1b (Mus musculus) 6480464 Capsaicin results in increased expression of CDKN1B CTD PMID:20069556 capsaicin increases expression ISO CDKN1B (Homo sapiens) 6480464 Capsaicin results in increased expression of CDKN1B protein CTD PMID:19855437 captan decreases expression ISO Cdkn1b (Mus musculus) 6480464 Captan results in decreased expression of CDKN1B mRNA CTD PMID:31558096 carbamazepine affects expression ISO CDKN1B (Homo sapiens) 6480464 Carbamazepine affects the expression of CDKN1B mRNA CTD PMID:24752500 carbon nanotube decreases expression ISO Cdkn1b (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25554681 carbonyl cyanide p-trifluoromethoxyphenylhydrazone multiple interactions ISO CDKN1B (Homo sapiens) 6480464 Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone promotes the reaction [CDKN1B protein binds to CDK4 protein] CTD PMID:19819288 carbonyl cyanide p-trifluoromethoxyphenylhydrazone increases expression ISO CDKN1B (Homo sapiens) 6480464 Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone results in increased expression of CDKN1B protein CTD PMID:19819288 carbonyl sulfide increases expression EXP 6480464 carbonyl sulfide results in increased expression of CDKN1B mRNA CTD PMID:19395590 carnosic acid increases expression ISO CDKN1B (Homo sapiens) 6480464 salvin results in increased expression of CDKN1B protein CTD PMID:23239002 carnosic acid multiple interactions ISO CDKN1B (Homo sapiens) 6480464 salvin promotes the reaction [arsenic trioxide results in increased expression of CDKN1B protein] CTD PMID:23239002 casticin increases expression ISO CDKN1B (Homo sapiens) 6480464 casticin results in increased expression of CDKN1B mRNA CTD PMID:27862857 cefaloridine decreases expression EXP 6480464 Cephaloridine results in decreased expression of CDKN1B mRNA CTD PMID:18500788 celecoxib multiple interactions ISO CDKN1B (Homo sapiens) 6480464 [Atorvastatin co-treated with Celecoxib] results in increased expression of CDKN1B protein more ... CTD PMID:18172863 and PMID:21737646 celecoxib increases expression ISO CDKN1B (Homo sapiens) 6480464 Celecoxib results in increased expression of CDKN1B mRNA and Celecoxib results in increased expression of CDKN1B protein CTD PMID:19428934 and PMID:21737646 chenodeoxycholic acid affects localization ISO CDKN1B (Homo sapiens) 6480464 Chenodeoxycholic Acid affects the localization of CDKN1B protein CTD PMID:20818264 chloropicrin increases expression ISO CDKN1B (Homo sapiens) 6480464 chloropicrin results in increased expression of CDKN1B protein CTD PMID:24548678 choline multiple interactions ISO Cdkn1b (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of CDKN1B gene CTD PMID:20938992 chromium(6+) increases expression EXP 6480464 chromium hexavalent ion results in increased expression of CDKN1B protein CTD PMID:21621607 and PMID:24530425 chromium(6+) multiple interactions ISO Cdkn1b (Mus musculus) 6480464 [chromium hexavalent ion co-treated with Benzo(a)pyrene] affects the expression of CDKN1B mRNA CTD PMID:25820237 chromium(6+) multiple interactions ISO CDKN1B (Homo sapiens) 6480464 AKT1 protein affects the reaction [Vanadates inhibits the reaction [chromium hexavalent ion affects the localization of CDKN1B protein]] more ... CTD PMID:19377290 ciglitazone increases expression EXP 6480464 ciglitazone results in increased expression of CDKN1B mRNA CTD PMID:20578043 cisplatin multiple interactions ISO CDKN1B (Homo sapiens) 6480464 [Cisplatin co-treated with Quercetin] results in increased expression of CDKN1B mRNA more ... CTD PMID:19636294 more ... cisplatin affects expression ISO CDKN1B (Homo sapiens) 6480464 Cisplatin affects the expression of CDKN1B protein CTD PMID:32562082 cisplatin decreases expression ISO Cdkn1b (Mus musculus) 6480464 Cisplatin results in decreased expression of CDKN1B mRNA CTD PMID:21151649 cisplatin increases expression ISO CDKN1B (Homo sapiens) 6480464 Cisplatin results in increased expression of CDKN1B mRNA and Cisplatin results in increased expression of CDKN1B protein CTD PMID:21092744 more ... cisplatin decreases response to substance ISO CDKN1B (Homo sapiens) 6480464 CDKN1B results in decreased susceptibility to Cisplatin CTD PMID:21652059 clobenpropit multiple interactions ISO CDKN1B (Homo sapiens) 6480464 [HRH4 protein results in increased susceptibility to clobenpropit] which results in increased expression of CDKN1B protein CTD PMID:22363581 clofibric acid multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of CDKN1B mRNA CTD PMID:17602206 clotrimazole increases expression ISO CDKN1B (Homo sapiens) 6480464 Clotrimazole results in increased expression of CDKN1B CTD PMID:20724915 copper atom multiple interactions ISO CDKN1B (Homo sapiens) 6480464 [Chelating Agents binds to Copper] which results in increased expression of CDKN1B mRNA and [Disulfiram binds to Copper] which results in increased expression of CDKN1B protein CTD PMID:24690739 and PMID:30911355 copper atom multiple interactions ISO Cdkn1b (Mus musculus) 6480464 [Disulfiram binds to Copper] which results in increased expression of CDKN1B protein CTD PMID:24690739 copper(0) multiple interactions ISO CDKN1B (Homo sapiens) 6480464 [Chelating Agents binds to Copper] which results in increased expression of CDKN1B mRNA and [Disulfiram binds to Copper] which results in increased expression of CDKN1B protein CTD PMID:24690739 and PMID:30911355 copper(0) multiple interactions ISO Cdkn1b (Mus musculus) 6480464 [Disulfiram binds to Copper] which results in increased expression of CDKN1B protein CTD PMID:24690739 copper(II) chloride affects expression ISO Cdkn1b (Mus musculus) 6480464 cupric chloride affects the expression of CDKN1B protein CTD PMID:23313662 cordycepin multiple interactions EXP 6480464 cordycepin promotes the reaction [CDK2 protein binds to CDKN1B protein] more ... CTD PMID:22366198 cordycepin multiple interactions ISO Cdkn1b (Mus musculus) 6480464 cordycepin results in decreased expression of and results in decreased phosphorylation of CDKN1B protein CTD PMID:31145545 cordycepin increases expression EXP 6480464 cordycepin results in increased expression of CDKN1B protein CTD PMID:22366198 corticosterone multiple interactions EXP 6480464 Corticosterone promotes the reaction [CDKN1B protein binds to CDK4 protein] CTD PMID:12807724 corticosterone increases expression EXP 6480464 Corticosterone results in increased expression of CDKN1B protein CTD PMID:12807724 CU-O LINKAGE decreases expression ISO CDKN1B (Homo sapiens) 6480464 cupric oxide results in decreased expression of CDKN1B mRNA CTD PMID:22077320 and PMID:32285662 cudraflavone B multiple interactions ISO CDKN1B (Homo sapiens) 6480464 resveratrol inhibits the reaction [cudraflavone B results in increased expression of CDKN1B protein] and sirtinol promotes the reaction [cudraflavone B results in increased expression of CDKN1B protein] CTD PMID:23881456 cudraflavone B increases expression ISO CDKN1B (Homo sapiens) 6480464 cudraflavone B results in increased expression of CDKN1B protein CTD PMID:23881456 curcumin increases expression ISO CDKN1B (Homo sapiens) 6480464 Curcumin results in increased expression of CDKN1B mRNA and Curcumin results in increased expression of CDKN1B protein CTD PMID:15713895 more ... curcumin increases expression EXP 6480464 Curcumin results in increased expression of CDKN1B protein CTD PMID:17602960 curcumin multiple interactions EXP 6480464 Buthionine Sulfoximine inhibits the reaction [Curcumin results in increased expression of CDKN1B protein] CTD PMID:17602960 curcumin multiple interactions ISO CDKN1B (Homo sapiens) 6480464 [arsenic trioxide co-treated with Curcumin] results in increased expression of CDKN1B protein more ... CTD PMID:18226269 more ... curcumin increases expression ISO Cdkn1b (Mus musculus) 6480464 Curcumin results in increased expression of CDKN1B mRNA and Curcumin results in increased expression of CDKN1B protein CTD PMID:21594647 and PMID:25822711 curcumin decreases expression ISO CDKN1B (Homo sapiens) 6480464 Curcumin results in decreased expression of CDKN1B protein CTD PMID:18593936 cyclophosphamide multiple interactions ISO CDKN1B (Homo sapiens) 6480464 [Doxorubicin co-treated with Cyclophosphamide] affects the expression of CDKN1B mRNA CTD PMID:16322899 cyclosporin A increases expression ISO CDKN1B (Homo sapiens) 6480464 Cyclosporine results in increased expression of CDKN1B mRNA CTD PMID:20106945 cyclosporin A decreases expression ISO CDKN1B (Homo sapiens) 6480464 Cyclosporine results in decreased expression of CDKN1B mRNA CTD PMID:25562108 cyclosporin A increases expression EXP 6480464 Cyclosporine results in increased expression of CDKN1B mRNA CTD PMID:21865292 cypermethrin decreases expression ISO Cdkn1b (Mus musculus) 6480464 cypermethrin results in decreased expression of CDKN1B mRNA CTD PMID:35031408 cytochalasin B increases expression ISO CDKN1B (Homo sapiens) 6480464 Cytochalasin B results in increased expression of CDKN1B protein CTD PMID:27640744 D-glucose increases expression EXP 6480464 Glucose results in increased expression of CDKN1B protein CTD PMID:22561310 D-glucose increases expression ISO CDKN1B (Homo sapiens) 6480464 Glucose results in increased expression of CDKN1B protein CTD PMID:33992720 D-glucose multiple interactions ISO CDKN1B (Homo sapiens) 6480464 [Glucose co-treated with Deferoxamine] results in increased expression of CDKN1B mRNA and Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of CDKN1B mRNA] CTD PMID:33962019 D-glucose multiple interactions EXP 6480464 NAD inhibits the reaction [Glucose results in increased expression of CDKN1B protein] more ... CTD PMID:22561310 daunorubicin multiple interactions EXP 6480464 fasudil affects the reaction [Daunorubicin affects the expression of CDKN1B mRNA] CTD PMID:20037814 daunorubicin affects expression EXP 6480464 Daunorubicin affects the expression of CDKN1B mRNA CTD PMID:20037814 decabromodiphenyl ether decreases expression ISO Cdkn1b (Mus musculus) 6480464 decabromobiphenyl ether results in decreased expression of CDKN1B protein CTD PMID:28572024 and PMID:29578053 deguelin increases expression ISO CDKN1B (Homo sapiens) 6480464 deguelin results in increased expression of CDKN1B mRNA CTD PMID:33512557 desferrioxamine B multiple interactions ISO CDKN1B (Homo sapiens) 6480464 [Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of CDKN1B mRNA more ... CTD PMID:33962019 and PMID:35690295 dexamethasone multiple interactions ISO Cdkn1b (Mus musculus) 6480464 5 more ... CTD PMID:24646949 more ... dexamethasone decreases expression EXP 6480464 Dexamethasone results in decreased expression of CDKN1B mRNA and Dexamethasone results in decreased expression of CDKN1B protein CTD PMID:34537908 dexamethasone decreases expression ISO CDKN1B (Homo sapiens) 6480464 Dexamethasone results in decreased expression of CDKN1B mRNA and Dexamethasone results in decreased expression of CDKN1B protein CTD PMID:34537908 dexamethasone multiple interactions EXP 6480464 [Polyribonucleotides results in decreased expression of MIR17 mRNA] inhibits the reaction [Dexamethasone results in decreased expression of CDKN1B mRNA] more ... CTD PMID:34537908 dexamethasone multiple interactions ISO CDKN1B (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CDKN1B mRNA more ... CTD PMID:28628672 and PMID:34537908 dexamethasone increases expression ISO CDKN1B (Homo sapiens) 6480464 Dexamethasone results in increased expression of CDKN1B mRNA and Dexamethasone results in increased expression of CDKN1B protein CTD PMID:19428934 diacetylmonoxime increases expression ISO Cdkn1b (Mus musculus) 6480464 diacetylmonoxime results in increased expression of CDKN1B protein CTD PMID:15252113 diallyl trisulfide increases expression ISO CDKN1B (Homo sapiens) 6480464 diallyl trisulfide results in increased expression of CDKN1B protein CTD PMID:14693049 diarsenic trioxide decreases expression ISO CDKN1B (Homo sapiens) 6480464 Arsenic Trioxide results in decreased expression of CDKN1B mRNA CTD PMID:19769630 diarsenic trioxide increases expression ISO CDKN1B (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of CDKN1B gene more ... CTD PMID:19236751 more ... diarsenic trioxide multiple interactions ISO CDKN1B (Homo sapiens) 6480464 [Arsenic Trioxide co-treated with Curcumin] results in increased expression of CDKN1B protein more ... CTD PMID:20698225 more ... dibenzofuran increases expression EXP 6480464 dibenzofuran analog results in increased expression of CDKN1B mRNA and dibenzofuran analog results in increased expression of CDKN1B protein CTD PMID:20566336 dibenzofuran multiple interactions EXP 6480464 AHR protein promotes the reaction [dibenzofuran analog results in increased expression of CDKN1B mRNA] CTD PMID:20566336 dibutyl phthalate multiple interactions ISO Cdkn1b (Mus musculus) 6480464 [diethyl phthalate co-treated with Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisobutyl phthalate co-treated with diisononyl phthalate] results in decreased expression of CDKN1B mRNA CTD PMID:37839492 diclofenac affects expression ISO CDKN1B (Homo sapiens) 6480464 Diclofenac affects the expression of CDKN1B mRNA CTD PMID:24752500 diethanolamine decreases expression ISO Cdkn1b (Mus musculus) 6480464 diethanolamine results in decreased expression of CDKN1B mRNA CTD PMID:16014740 diethanolamine decreases expression EXP 6480464 diethanolamine results in decreased expression of CDKN1B mRNA CTD PMID:16014740 diethyl phthalate multiple interactions ISO Cdkn1b (Mus musculus) 6480464 [diethyl phthalate co-treated with Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisobutyl phthalate co-treated with diisononyl phthalate] results in decreased expression of CDKN1B mRNA CTD PMID:37839492 diethylstilbestrol increases expression EXP 6480464 Diethylstilbestrol results in increased expression of CDKN1B mRNA CTD PMID:17292805 diethylstilbestrol decreases expression EXP 6480464 Diethylstilbestrol results in decreased expression of CDKN1B mRNA CTD PMID:21658437 digitonin decreases expression ISO Cdkn1b (Mus musculus) 6480464 Digitonin results in decreased expression of CDKN1B protein CTD PMID:36030841 digitoxin decreases expression ISO CDKN1B (Homo sapiens) 6480464 Digitoxin analog results in decreased expression of CDKN1B protein and Digitoxin results in decreased expression of CDKN1B protein CTD PMID:22037315 diisobutyl phthalate multiple interactions ISO Cdkn1b (Mus musculus) 6480464 [diethyl phthalate co-treated with Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisobutyl phthalate co-treated with diisononyl phthalate] results in decreased expression of CDKN1B mRNA CTD PMID:37839492 diisononyl phthalate multiple interactions ISO Cdkn1b (Mus musculus) 6480464 [diethyl phthalate co-treated with Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisobutyl phthalate co-treated with diisononyl phthalate] results in decreased expression of CDKN1B mRNA CTD PMID:37839492 dimethyldithiocarbamate multiple interactions ISO CDKN1B (Homo sapiens) 6480464 [Gold binds to Dimethyldithiocarbamate] which results in increased expression of CDKN1B protein CTD PMID:17079469 dioscin increases expression ISO CDKN1B (Homo sapiens) 6480464 dioscin results in increased expression of CDKN1B mRNA and dioscin results in increased expression of CDKN1B protein CTD PMID:33359023 dioxygen increases expression ISO CDKN1B (Homo sapiens) 6480464 Oxygen deficiency results in increased expression of CDKN1B mRNA CTD PMID:17914565 disodium selenite increases expression EXP 6480464 Sodium Selenite results in increased expression of CDKN1B protein CTD PMID:19276161 disulfiram increases expression ISO CDKN1B (Homo sapiens) 6480464 Disulfiram results in increased expression of CDKN1B protein CTD PMID:17079463 disulfiram multiple interactions ISO Cdkn1b (Mus musculus) 6480464 [Disulfiram binds to Copper] which results in increased expression of CDKN1B protein CTD PMID:24690739 disulfiram multiple interactions ISO CDKN1B (Homo sapiens) 6480464 [Disulfiram binds to Copper] which results in increased expression of CDKN1B protein CTD PMID:24690739 divanadium pentaoxide decreases expression ISO CDKN1B (Homo sapiens) 6480464 vanadium pentoxide results in decreased expression of CDKN1B mRNA CTD PMID:17459161 doxorubicin affects expression ISO CDKN1B (Homo sapiens) 6480464 Doxorubicin affects the expression of CDKN1B mRNA and Doxorubicin affects the expression of CDKN1B protein CTD PMID:16036217 more ... doxorubicin increases expression ISO CDKN1B (Homo sapiens) 6480464 Doxorubicin results in increased expression of CDKN1B protein CTD PMID:17935137 doxorubicin multiple interactions ISO CDKN1B (Homo sapiens) 6480464 [Doxorubicin co-treated with Cyclophosphamide] affects the expression of CDKN1B mRNA and wortmannin promotes the reaction [Doxorubicin results in increased expression of CDKN1B protein] CTD PMID:16322899 and PMID:17935137 doxorubicin decreases response to substance ISO CDKN1B (Homo sapiens) 6480464 CDKN1B results in decreased susceptibility to Doxorubicin CTD PMID:21652059 ellipticine decreases expression ISO CDKN1B (Homo sapiens) 6480464 ellipticine results in decreased expression of CDKN1B protein CTD PMID:21843585 endosulfan decreases expression ISO CDKN1B (Homo sapiens) 6480464 Endosulfan results in decreased expression of CDKN1B mRNA CTD PMID:34856488 entinostat multiple interactions ISO CDKN1B (Homo sapiens) 6480464 [fludarabine co-treated with entinostat] results in decreased expression of CDKN1B protein CTD PMID:15059916 enzalutamide affects expression ISO CDKN1B (Homo sapiens) 6480464 enzalutamide affects the expression of CDKN1B mRNA CTD PMID:30940724 epoxiconazole decreases expression ISO Cdkn1b (Mus musculus) 6480464 epoxiconazole results in decreased expression of CDKN1B mRNA CTD PMID:35436446 esculetin increases expression ISO CDKN1B (Homo sapiens) 6480464 esculetin results in increased expression of CDKN1B protein CTD PMID:31313495 etoposide increases expression ISO CDKN1B (Homo sapiens) 6480464 Etoposide results in increased expression of CDKN1B protein CTD PMID:17935137 etoposide multiple interactions ISO CDKN1B (Homo sapiens) 6480464 wortmannin promotes the reaction [Etoposide results in increased expression of CDKN1B protein] CTD PMID:17935137 eugenol increases expression ISO CDKN1B (Homo sapiens) 6480464 Eugenol results in increased expression of CDKN1B protein CTD PMID:22686307 farnesol increases response to substance ISO CDKN1B (Homo sapiens) 6480464 CDKN1B protein results in increased susceptibility to Farnesol CTD PMID:17138864 farnesol multiple interactions ISO CDKN1B (Homo sapiens) 6480464 Farnesol promotes the reaction [CDKN1B protein binds to and results in decreased activity of CDK2 protein] CTD PMID:17138864 farnesol increases expression ISO CDKN1B (Homo sapiens) 6480464 Farnesol results in increased expression of CDKN1B protein CTD PMID:17138864 fasudil multiple interactions EXP 6480464 fasudil affects the reaction [Daunorubicin affects the expression of CDKN1B mRNA] CTD PMID:20037814 fenofibrate multiple interactions EXP 6480464 [Fenofibrate co-treated with Diethylnitrosamine] results in decreased expression of CDKN1B mRNA CTD PMID:18253720 fenofibrate multiple interactions ISO CDKN1B (Homo sapiens) 6480464 ESR1 protein inhibits the reaction [Fenofibrate results in decreased expression of CDKN1B protein] and Estradiol inhibits the reaction [Fenofibrate results in decreased expression of CDKN1B protein] CTD PMID:29134746 fenofibrate decreases expression ISO CDKN1B (Homo sapiens) 6480464 Fenofibrate results in decreased expression of CDKN1B protein CTD PMID:29134746 fenvalerate multiple interactions ISO CDKN1B (Homo sapiens) 6480464 CDKN1B protein inhibits the reaction [fenvalerate results in increased expression of CDK2 mRNA] CTD PMID:22850687 fenvalerate decreases response to substance ISO CDKN1B (Homo sapiens) 6480464 CDKN1B protein results in decreased susceptibility to fenvalerate CTD PMID:22850687 fenvalerate decreases expression ISO CDKN1B (Homo sapiens) 6480464 fenvalerate results in decreased expression of CDKN1B mRNA and fenvalerate results in decreased expression of CDKN1B protein CTD PMID:22850687 ferric oxide multiple interactions EXP 6480464 [ferric oxide analog co-treated with Acrolein] results in decreased expression of CDKN1B protein CTD PMID:24847785 flavanone increases expression ISO CDKN1B (Homo sapiens) 6480464 flavanone results in increased expression of CDKN1B protein CTD PMID:22056764 fluoxetine increases expression ISO Cdkn1b (Mus musculus) 6480464 Fluoxetine results in increased expression of CDKN1B mRNA CTD PMID:21497159 fluoxetine affects expression ISO CDKN1B (Homo sapiens) 6480464 Fluoxetine affects the expression of CDKN1B mRNA CTD PMID:18371935 fluoxetine multiple interactions ISO CDKN1B (Homo sapiens) 6480464 [Fluoxetine results in decreased activity of CKS1B protein] which results in decreased degradation of CDKN1B protein CTD PMID:18371935 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of CDKN1B mRNA CTD PMID:24136188 folic acid affects expression ISO CDKN1B (Homo sapiens) 6480464 Folic Acid affects the expression of CDKN1B mRNA CTD PMID:16361273 folic acid increases expression ISO CDKN1B (Homo sapiens) 6480464 Folic Acid results in increased expression of CDKN1B protein CTD PMID:26056802 folic acid multiple interactions ISO CDKN1B (Homo sapiens) 6480464 AG 1879 inhibits the reaction [Folic Acid results in increased expression of CDKN1B protein] more ... CTD PMID:26056802 folic acid multiple interactions ISO Cdkn1b (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of CDKN1B gene more ... CTD PMID:20938992 and PMID:22206623 folpet decreases expression ISO Cdkn1b (Mus musculus) 6480464 folpet results in decreased expression of CDKN1B mRNA CTD PMID:31558096 formaldehyde decreases expression ISO CDKN1B (Homo sapiens) 6480464 Formaldehyde results in decreased expression of CDKN1B protein CTD PMID:30236600 FR900359 increases phosphorylation ISO CDKN1B (Homo sapiens) 6480464 FR900359 results in increased phosphorylation of CDKN1B protein CTD PMID:37730182 fulvestrant multiple interactions ISO CDKN1B (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of CDKN1B gene more ... CTD PMID:17283133 more ... fulvestrant increases expression ISO CDKN1B (Homo sapiens) 6480464 fulvestrant results in increased expression of CDKN1B protein CTD PMID:21367843 furan increases expression EXP 6480464 furan results in increased expression of CDKN1B mRNA CTD PMID:22079235 gallic acid increases expression ISO CDKN1B (Homo sapiens) 6480464 Gallic Acid results in increased expression of CDKN1B protein CTD PMID:22245431 gamma-tocopherol decreases expression ISO CDKN1B (Homo sapiens) 6480464 gamma-Tocopherol results in decreased expression of CDKN1B protein CTD PMID:12368234 ganglioside GM1 decreases expression EXP 6480464 G(M1) Ganglioside results in decreased expression of CDKN1B protein CTD PMID:15654767 gefitinib multiple interactions ISO CDKN1B (Homo sapiens) 6480464 gefitinib promotes the reaction [[zoledronic acid co-treated with 4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide] results in decreased expression of CDKN1B protein] CTD PMID:16322342 gefitinib increases expression ISO CDKN1B (Homo sapiens) 6480464 gefitinib results in increased expression of CDKN1B protein CTD PMID:16740687 and PMID:17513607 gefitinib decreases expression ISO CDKN1B (Homo sapiens) 6480464 gefitinib results in decreased expression of CDKN1B CTD PMID:14679152 gemcitabine decreases response to substance ISO CDKN1B (Homo sapiens) 6480464 CDKN1B results in decreased susceptibility to Gemcitabine CTD PMID:21652059 genistein increases expression ISO CDKN1B (Homo sapiens) 6480464 Genistein results in increased expression of CDKN1B protein CTD PMID:15829497 genistein decreases expression ISO Cdkn1b (Mus musculus) 6480464 Genistein results in decreased expression of CDKN1B mRNA CTD PMID:31593742 genistein increases expression ISO Cdkn1b (Mus musculus) 6480464 Genistein results in increased expression of CDKN1B mRNA CTD PMID:21048042 geraniol increases expression ISO CDKN1B (Homo sapiens) 6480464 geraniol results in increased expression of CDKN1B protein CTD PMID:17138864 and PMID:21371438 geraniol increases response to substance ISO CDKN1B (Homo sapiens) 6480464 CDKN1B protein results in increased susceptibility to geraniol CTD PMID:17138864 geraniol multiple interactions ISO CDKN1B (Homo sapiens) 6480464 geraniol promotes the reaction [CDKN1B protein binds to and results in decreased activity of CDK2 protein] CTD PMID:17138864 gingerol decreases expression ISO CDKN1B (Homo sapiens) 6480464 gingerol results in decreased expression of CDKN1B mRNA CTD PMID:28249781 glafenine decreases expression EXP 6480464 Glafenine results in decreased expression of CDKN1B mRNA CTD PMID:24136188 glucose multiple interactions EXP 6480464 NAD inhibits the reaction [Glucose results in increased expression of CDKN1B protein] more ... CTD PMID:22561310 glucose increases expression ISO CDKN1B (Homo sapiens) 6480464 Glucose results in increased expression of CDKN1B protein CTD PMID:33992720 glucose multiple interactions ISO CDKN1B (Homo sapiens) 6480464 [Glucose co-treated with Deferoxamine] results in increased expression of CDKN1B mRNA and Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of CDKN1B mRNA] CTD PMID:33962019 glucose increases expression EXP 6480464 Glucose results in increased expression of CDKN1B protein CTD PMID:22561310 glycyrrhetinate multiple interactions ISO CDKN1B (Homo sapiens) 6480464 18alpha-glycyrrhetinic acid inhibits the reaction [[PDGFB protein co-treated with PDGFB protein] results in decreased expression of CDKN1B protein] CTD PMID:31325423 glycyrrhetinic acid multiple interactions ISO CDKN1B (Homo sapiens) 6480464 18alpha-glycyrrhetinic acid inhibits the reaction [[PDGFB protein co-treated with PDGFB protein] results in decreased expression of CDKN1B protein] CTD PMID:31325423 glyphosate decreases expression EXP 6480464 Glyphosate results in decreased expression of CDKN1B protein CTD PMID:27486271 glyphosate increases expression ISO CDKN1B (Homo sapiens) 6480464 Glyphosate results in increased expression of CDKN1B mRNA CTD PMID:31295307 gold atom multiple interactions ISO CDKN1B (Homo sapiens) 6480464 [Gold binds to Dimethyldithiocarbamate] which results in increased expression of CDKN1B protein CTD PMID:17079469 gold(0) multiple interactions ISO CDKN1B (Homo sapiens) 6480464 [Gold binds to Dimethyldithiocarbamate] which results in increased expression of CDKN1B protein CTD PMID:17079469 guggulsterone increases expression ISO CDKN1B (Homo sapiens) 6480464 pregna-4 more ... CTD PMID:17475222 harmine decreases phosphorylation EXP 6480464 Harmine results in decreased phosphorylation of CDKN1B protein CTD PMID:26953159 hemin decreases degradation ISO CDKN1B (Homo sapiens) 6480464 Hemin results in decreased degradation of CDKN1B protein CTD PMID:17283133 heparin decreases expression ISO CDKN1B (Homo sapiens) 6480464 Heparin analog results in decreased expression of CDKN1B protein CTD PMID:20201787 heparin increases expression ISO CDKN1B (Homo sapiens) 6480464 Heparin analog results in increased expression of CDKN1B protein CTD PMID:18057711 hesperetin increases expression ISO CDKN1B (Homo sapiens) 6480464 hesperetin results in increased expression of CDKN1B CTD PMID:17927510 hesperidin multiple interactions ISO CDKN1B (Homo sapiens) 6480464 BIX 02189 promotes the reaction [Hesperidin results in increased expression of CDKN1B mRNA] and BIX 02189 promotes the reaction [Hesperidin results in increased expression of CDKN1B protein] CTD PMID:34984768 hesperidin increases expression ISO CDKN1B (Homo sapiens) 6480464 Hesperidin results in increased expression of CDKN1B mRNA and Hesperidin results in increased expression of CDKN1B protein CTD PMID:34984768 hexachlorobenzene increases expression EXP 6480464 Hexachlorobenzene results in increased expression of CDKN1B protein CTD PMID:25093615 hexachlorobenzene multiple interactions ISO CDKN1B (Homo sapiens) 6480464 Hexachlorobenzene affects the reaction [CDKN1B protein binds to SRC protein] and Hexachlorobenzene promotes the reaction [CDKN1B protein binds to CCNE1 protein] CTD PMID:28215542 hexadecanoic acid decreases phosphorylation ISO CDKN1B (Homo sapiens) 6480464 Palmitic Acid results in decreased phosphorylation of CDKN1B protein CTD PMID:28073184 histamine multiple interactions ISO CDKN1B (Homo sapiens) 6480464 [HRH4 protein results in increased susceptibility to Histamine] which results in increased expression of CDKN1B protein CTD PMID:22363581 hydralazine multiple interactions EXP 6480464 [troglitazone co-treated with [Hydrochlorothiazide co-treated with Hydralazine co-treated with Reserpine]] results in decreased expression of CDKN1B protein CTD PMID:11318962 hydrochlorothiazide multiple interactions EXP 6480464 [troglitazone co-treated with [Hydrochlorothiazide co-treated with Hydralazine co-treated with Reserpine]] results in decreased expression of CDKN1B protein CTD PMID:11318962 hydrogen chloride affects localization ISO CDKN1B (Homo sapiens) 6480464 Hydrochloric Acid affects the localization of CDKN1B protein CTD PMID:20818264 hydroxyurea increases expression ISO CDKN1B (Homo sapiens) 6480464 Hydroxyurea results in increased expression of CDKN1B protein CTD PMID:10961388 hydroxyurea multiple interactions ISO CDKN1B (Homo sapiens) 6480464 [Valproic Acid co-treated with Hydroxyurea] results in increased expression of CDKN1B mRNA CTD PMID:17653085 indirubin increases expression ISO Cdkn1b (Mus musculus) 6480464 indirubin results in increased expression of CDKN1B protein CTD PMID:18344322 indirubin multiple interactions ISO Cdkn1b (Mus musculus) 6480464 indirubin promotes the reaction [tanshinone promotes the reaction [tetraarsenic tetrasulfide results in increased expression of CDKN1B protein]] more ... CTD PMID:18344322 indole-3-methanol increases expression ISO CDKN1B (Homo sapiens) 6480464 indole-3-carbinol analog results in increased expression of CDKN1B protein and indole-3-carbinol results in increased expression of CDKN1B CTD PMID:16082211 and PMID:20570586 indometacin decreases expression ISO CDKN1B (Homo sapiens) 6480464 Indomethacin results in decreased expression of CDKN1B mRNA CTD PMID:16984733 indometacin multiple interactions ISO CDKN1B (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CDKN1B mRNA more ... CTD PMID:28628672 indometacin increases expression ISO CDKN1B (Homo sapiens) 6480464 Indomethacin results in increased expression of CDKN1B mRNA and Indomethacin results in increased expression of CDKN1B protein CTD PMID:11260862 and PMID:19428934 inulin multiple interactions ISO Cdkn1b (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of CDKN1B mRNA CTD PMID:36331819 isoeugenol increases expression ISO CDKN1B (Homo sapiens) 6480464 isoeugenol results in increased expression of CDKN1B protein CTD PMID:22686307 isoflavones increases expression ISO CDKN1B (Homo sapiens) 6480464 Isoflavones results in increased expression of CDKN1B protein CTD PMID:17374662 isoliquiritigenin decreases expression ISO Cdkn1b (Mus musculus) 6480464 isoliquiritigenin results in decreased expression of CDKN1B mRNA CTD PMID:27702603 isoprene decreases expression ISO CDKN1B (Homo sapiens) 6480464 isoprene results in decreased expression of CDKN1B protein CTD PMID:30236600 isosilybin A increases expression ISO CDKN1B (Homo sapiens) 6480464 isosilybin A results in increased expression of CDKN1B protein CTD PMID:18435416 ivermectin increases expression ISO CDKN1B (Homo sapiens) 6480464 Ivermectin results in increased expression of CDKN1B protein CTD PMID:28811376 ivermectin decreases expression ISO CDKN1B (Homo sapiens) 6480464 Ivermectin results in decreased expression of CDKN1B protein CTD PMID:32959892 ketoconazole increases expression EXP 6480464 Ketoconazole results in increased expression of CDKN1B mRNA CTD PMID:25808816 kojic acid multiple interactions EXP 6480464 [Ascorbic Acid co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CDKN1B mRNA and [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CDKN1B mRNA CTD PMID:18544905 L-ascorbic acid multiple interactions EXP 6480464 [Ascorbic Acid co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CDKN1B mRNA CTD PMID:18544905 L-cysteine decreases expression ISO CDKN1B (Homo sapiens) 6480464 Cysteine analog results in decreased expression of CDKN1B protein CTD PMID:15890017 L-methionine multiple interactions ISO Cdkn1b (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of CDKN1B gene CTD PMID:20938992 L-mimosine increases expression ISO CDKN1B (Homo sapiens) 6480464 Mimosine results in increased expression of CDKN1B CTD PMID:10530763 lactacystin increases expression ISO CDKN1B (Homo sapiens) 6480464 lactacystin results in increased expression of CDKN1B protein CTD PMID:12149143 lactacystin multiple interactions ISO CDKN1B (Homo sapiens) 6480464 lactacystin inhibits the reaction [Estradiol results in increased degradation of CDKN1B protein] CTD PMID:17283133 and PMID:23029392 lamivudine multiple interactions ISO CDKN1B (Homo sapiens) 6480464 [Zidovudine co-treated with Lamivudine] results in decreased expression of CDKN1B mRNA CTD PMID:15784690 lapatinib multiple interactions ISO CDKN1B (Homo sapiens) 6480464 [afimoxifene co-treated with Lapatinib] promotes the reaction [CDKN1B protein binds to and results in decreased activity of [CCNE1 protein binds to CDK2 protein]] more ... CTD PMID:15665275 more ... lapatinib increases expression ISO CDKN1B (Homo sapiens) 6480464 lapatinib results in increased expression of CDKN1B protein CTD PMID:15665275 and PMID:20701607 Licochalcone B increases expression ISO CDKN1B (Homo sapiens) 6480464 licochalcone B results in increased expression of CDKN1B protein CTD PMID:35948134 lidocaine affects expression ISO Cdkn1b (Mus musculus) 6480464 Lidocaine affects the expression of CDKN1B mRNA CTD PMID:18931217 linalool increases expression ISO CDKN1B (Homo sapiens) 6480464 linalool results in increased expression of CDKN1B mRNA CTD PMID:19922762 lipopolysaccharide multiple interactions ISO Cdkn1b (Mus musculus) 6480464 Tetrachlorodibenzodioxin inhibits the reaction [Lipopolysaccharides affects the expression of CDKN1B protein] more ... CTD PMID:12883080 lipopolysaccharide increases expression ISO Cdkn1b (Mus musculus) 6480464 Lipopolysaccharides results in increased expression of CDKN1B mRNA and Lipopolysaccharides results in increased expression of CDKN1B protein alternative form CTD PMID:12883080 lipopolysaccharide affects expression ISO Cdkn1b (Mus musculus) 6480464 Lipopolysaccharides affects the expression of CDKN1B protein CTD PMID:12883080 lithium atom decreases expression EXP 6480464 Lithium results in decreased expression of CDKN1B mRNA and Lithium results in decreased expression of CDKN1B protein CTD PMID:15687245 and PMID:18296634 lithium chloride decreases expression ISO CDKN1B (Homo sapiens) 6480464 Lithium Chloride results in decreased expression of CDKN1B mRNA CTD PMID:17440966 lithium hydride decreases expression EXP 6480464 Lithium results in decreased expression of CDKN1B mRNA and Lithium results in decreased expression of CDKN1B protein CTD PMID:15687245 and PMID:18296634 lovastatin increases expression EXP 6480464 Lovastatin results in increased expression of CDKN1B mRNA and Lovastatin results in increased expression of CDKN1B protein CTD PMID:20578043 and PMID:9848777 lovastatin increases expression ISO CDKN1B (Homo sapiens) 6480464 Lovastatin results in increased expression of CDKN1B protein CTD PMID:10502407 more ... luteolin increases expression ISO CDKN1B (Homo sapiens) 6480464 Luteolin results in increased expression of CDKN1B protein CTD PMID:11322924 LY294002 multiple interactions ISO CDKN1B (Homo sapiens) 6480464 [decitabine co-treated with 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one co-treated with Sirolimus] results in increased expression of CDKN1B mRNA and [resveratrol co-treated with 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one] results in increased expression of CDKN1B protein CTD PMID:18622747 and PMID:21179458 LY294002 increases expression ISO CDKN1B (Homo sapiens) 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased expression of CDKN1B protein CTD PMID:11322924 more ... LY294002 increases expression ISO Cdkn1b (Mus musculus) 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased expression of CDKN1B protein CTD PMID:15601625 Maxacalcitol increases expression ISO CDKN1B (Homo sapiens) 6480464 maxacalcitol results in increased expression of CDKN1B protein CTD PMID:16039115 medroxyprogesterone acetate multiple interactions ISO CDKN1B (Homo sapiens) 6480464 Estradiol promotes the reaction [Medroxyprogesterone Acetate results in increased expression of CDKN1B protein] and Mifepristone inhibits the reaction [[Medroxyprogesterone Acetate co-treated with Estradiol] results in increased expression of CDKN1B protein] CTD PMID:17283133 medroxyprogesterone acetate increases expression ISO CDKN1B (Homo sapiens) 6480464 Medroxyprogesterone Acetate results in increased expression of CDKN1B protein CTD PMID:17283133 melatonin multiple interactions ISO CDKN1B (Homo sapiens) 6480464 Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of CDKN1B mRNA] CTD PMID:33962019 menadione multiple interactions ISO CDKN1B (Homo sapiens) 6480464 [sodium arsenite co-treated with Vitamin K 3] results in increased expression of CDKN1B protein and SB 203580 inhibits the reaction [[sodium arsenite co-treated with Vitamin K 3] results in increased expression of CDKN1B protein] CTD PMID:19082730 metformin multiple interactions ISO CDKN1B (Homo sapiens) 6480464 [Paclitaxel co-treated with Metformin] results in increased expression of CDKN1B mRNA CTD PMID:29309887 methidathion increases expression ISO Cdkn1b (Mus musculus) 6480464 methidathion results in increased expression of CDKN1B mRNA CTD PMID:34813904 methotrexate affects response to substance ISO CDKN1B (Homo sapiens) 6480464 CDKN1B protein affects the susceptibility to Methotrexate CTD PMID:17217824 methotrexate increases expression ISO CDKN1B (Homo sapiens) 6480464 Methotrexate results in increased expression of CDKN1B mRNA CTD PMID:22183962 methoxsalen multiple interactions ISO CDKN1B (Homo sapiens) 6480464 Methoxsalen inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CDKN1B protein] CTD PMID:15157999 methylseleninic acid multiple interactions ISO CDKN1B (Homo sapiens) 6480464 KLF4 protein affects the reaction [methylselenic acid results in increased expression of CDKN1B mRNA] more ... CTD PMID:17847021 and PMID:18314491 methylseleninic acid affects expression EXP 6480464 methylselenic acid affects the expression of CDKN1B protein CTD PMID:12017302 methylseleninic acid increases expression ISO CDKN1B (Homo sapiens) 6480464 methylselenic acid results in increased expression of CDKN1B mRNA and methylselenic acid results in increased expression of CDKN1B protein CTD PMID:17847021 and PMID:18314491 mifepristone multiple interactions ISO CDKN1B (Homo sapiens) 6480464 Mifepristone inhibits the reaction [[Medroxyprogesterone Acetate co-treated with Estradiol] results in increased expression of CDKN1B protein] more ... CTD PMID:17283133 more ... mifepristone increases expression ISO CDKN1B (Homo sapiens) 6480464 Mifepristone results in increased expression of CDKN1B mRNA and Mifepristone results in increased expression of CDKN1B protein CTD PMID:34537908 minocycline increases expression ISO CDKN1B (Homo sapiens) 6480464 Minocycline results in increased expression of CDKN1B mRNA and Minocycline results in increased expression of CDKN1B protein CTD PMID:21719015 mitomycin C affects response to substance ISO CDKN1B (Homo sapiens) 6480464 CDKN1B protein affects the susceptibility to Mitomycin CTD PMID:17217824 ML-7 increases expression ISO Cdkn1b (Mus musculus) 6480464 ML 7 results in increased expression of CDKN1B protein CTD PMID:15252113 mono(2-ethylhexyl) phthalate multiple interactions ISO Cdkn1b (Mus musculus) 6480464 [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of CDKN1B mRNA CTD PMID:31884101 monobenzyl phthalate multiple interactions ISO Cdkn1b (Mus musculus) 6480464 [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of CDKN1B mRNA CTD PMID:31884101 monoethyl phthalate multiple interactions ISO Cdkn1b (Mus musculus) 6480464 [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of CDKN1B mRNA CTD PMID:31884101 monosodium L-glutamate multiple interactions ISO Cdkn1b (Mus musculus) 6480464 [Fats and Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of CDKN1B mRNA CTD PMID:23783067 motexafin gadolinium increases expression ISO CDKN1B (Homo sapiens) 6480464 motexafin gadolinium results in increased expression of CDKN1B mRNA CTD PMID:16357179 motexafin gadolinium multiple interactions ISO CDKN1B (Homo sapiens) 6480464 [Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of CDKN1B mRNA CTD PMID:16357179 mycophenolic acid multiple interactions ISO CDKN1B (Homo sapiens) 6480464 Mycophenolic Acid inhibits the reaction [IL2 protein results in decreased expression of CDKN1B protein] CTD PMID:12193749 myo-inositol hexakisphosphate decreases expression ISO CDKN1B (Homo sapiens) 6480464 Phytic Acid results in decreased expression of CDKN1B protein CTD PMID:15868430 N-(6-acetamidohexyl)acetamide increases expression ISO CDKN1B (Homo sapiens) 6480464 hexamethylene bisacetamide results in increased expression of CDKN1B mRNA CTD PMID:17349212 N-acetyl-L-cysteine increases expression EXP 6480464 Acetylcysteine results in increased expression of CDKN1B protein CTD PMID:17602960 N-acetyl-L-cysteine multiple interactions ISO CDKN1B (Homo sapiens) 6480464 Acetylcysteine inhibits the reaction [Methylcholanthrene results in increased expression of CDKN1B protein] more ... CTD PMID:18022818 and PMID:30917517 N-acetyl-L-cysteine multiple interactions EXP 6480464 Buthionine Sulfoximine inhibits the reaction [Acetylcysteine results in increased expression of CDKN1B protein] CTD PMID:17602960 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal decreases degradation ISO CDKN1B (Homo sapiens) 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased degradation of CDKN1B protein CTD PMID:17283133 N-methyl-N'-nitro-N-nitrosoguanidine increases expression ISO Cdkn1b (Mus musculus) 6480464 Methylnitronitrosoguanidine results in increased expression of CDKN1B protein CTD PMID:11516527 and PMID:12135628 N-methyl-N'-nitro-N-nitrosoguanidine multiple interactions ISO Cdkn1b (Mus musculus) 6480464 Cadmium Chloride inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of CDKN1B protein] and Cadmium Chloride promotes the reaction [Methylnitronitrosoguanidine results in decreased expression of CDKN1B mRNA] CTD PMID:11516527 and PMID:12135628 N-methyl-N'-nitro-N-nitrosoguanidine decreases expression ISO Cdkn1b (Mus musculus) 6480464 Methylnitronitrosoguanidine results in decreased expression of CDKN1B mRNA CTD PMID:12135628 N-nitrosodiethylamine multiple interactions EXP 6480464 2-Acetylaminofluorene promotes the reaction [Diethylnitrosamine results in decreased expression of CDKN1B protein] more ... CTD PMID:17582756 more ... N-nitrosodiethylamine decreases expression EXP 6480464 Diethylnitrosamine results in decreased expression of CDKN1B protein CTD PMID:17582756 N-nitrosodiethylamine multiple interactions ISO Cdkn1b (Mus musculus) 6480464 CDKN1B protein inhibits the reaction [[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of CDK2 protein] and CDKN1B results in decreased susceptibility to [Diethylnitrosamine co-treated with Phenobarbital] CTD PMID:17620307 NAD zwitterion multiple interactions EXP 6480464 NAD inhibits the reaction [Glucose results in increased expression of CDKN1B protein] and SIRT1 protein promotes the reaction [NAD inhibits the reaction [Glucose results in increased expression of CDKN1B protein]] CTD PMID:22561310 NAD(+) multiple interactions EXP 6480464 NAD inhibits the reaction [Glucose results in increased expression of CDKN1B protein] and SIRT1 protein promotes the reaction [NAD inhibits the reaction [Glucose results in increased expression of CDKN1B protein]] CTD PMID:22561310 naphthalene decreases expression ISO Cdkn1b (Mus musculus) 6480464 naphthalene results in decreased expression of CDKN1B protein CTD PMID:18687389 nickel dichloride affects expression EXP 6480464 nickel chloride affects the expression of CDKN1B mRNA CTD PMID:22546817 nickel dichloride multiple interactions ISO CDKN1B (Homo sapiens) 6480464 HIF1A protein promotes the reaction [nickel chloride results in increased expression of CDKN1B protein] CTD PMID:28552779 nickel dichloride increases expression ISO CDKN1B (Homo sapiens) 6480464 nickel chloride results in increased expression of CDKN1B protein CTD PMID:28552779 nickel subsulfide decreases expression EXP 6480464 nickel subsulfide results in decreased expression of CDKN1B CTD PMID:23447020 nicotinamide increases expression EXP 6480464 Niacinamide results in increased expression of CDKN1B protein CTD PMID:22561310 nicotinamide multiple interactions EXP 6480464 Niacinamide inhibits the reaction [Sirolimus inhibits the reaction [Glucose results in increased expression of CDKN1B protein]] CTD PMID:22561310 nicotine multiple interactions ISO CDKN1B (Homo sapiens) 6480464 4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide inhibits the reaction [Nicotine results in decreased expression of CDKN1B protein] and Nicotine results in increased expression of and results in increased stability of CDKN1B protein CTD PMID:15231866 and PMID:18805435 nicotine decreases expression ISO CDKN1B (Homo sapiens) 6480464 Nicotine results in decreased expression of CDKN1B protein CTD PMID:18805435 nilutamide decreases expression ISO Cdkn1b (Mus musculus) 6480464 nilutamide results in decreased expression of CDKN1B protein CTD PMID:16616092 nimesulide increases expression ISO CDKN1B (Homo sapiens) 6480464 nimesulide results in increased expression of CDKN1B and nimesulide results in increased expression of CDKN1B protein CTD PMID:12717830 and PMID:14567460 nitroglycerin increases expression EXP 6480464 Nitroglycerin results in increased expression of CDKN1B mRNA CTD PMID:12102619 NS-398 multiple interactions ISO CDKN1B (Homo sapiens) 6480464 N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [VEGFC protein results in decreased expression of CDKN1B protein] CTD PMID:24184161 NS-398 increases expression ISO CDKN1B (Homo sapiens) 6480464 N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in increased expression of CDKN1B protein CTD PMID:14567460 ochratoxin A decreases expression ISO CDKN1B (Homo sapiens) 6480464 ochratoxin A results in decreased expression of CDKN1B mRNA CTD PMID:30763683 ochratoxin A multiple interactions ISO CDKN1B (Homo sapiens) 6480464 [Citrinin co-treated with ochratoxin A] results in decreased expression of CDKN1B mRNA and [Citrinin co-treated with ochratoxin A] results in increased expression of CDKN1B mRNA CTD PMID:30428381 ochratoxin A increases expression ISO CDKN1B (Homo sapiens) 6480464 ochratoxin A results in increased expression of CDKN1B mRNA CTD PMID:30428381 orlistat increases expression ISO CDKN1B (Homo sapiens) 6480464 orlistat results in increased expression of CDKN1B protein CTD PMID:15138278 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of CDKN1B mRNA CTD PMID:25729387 oxaliplatin increases expression ISO Cdkn1b (Mus musculus) 6480464 Oxaliplatin results in increased expression of CDKN1B protein CTD PMID:30031110 oxaliplatin increases expression ISO CDKN1B (Homo sapiens) 6480464 oxaliplatin results in increased expression of CDKN1B protein CTD PMID:15204521 ozone multiple interactions ISO Cdkn1b (Mus musculus) 6480464 [Air Pollutants results in increased abundance of Ozone] which results in increased expression of CDKN1B mRNA CTD PMID:27106289 p-tert-Amylphenol increases phosphorylation ISO CDKN1B (Homo sapiens) 6480464 4-tert-octylphenol results in increased phosphorylation of CDKN1B protein CTD PMID:32466334 paclitaxel multiple interactions ISO CDKN1B (Homo sapiens) 6480464 [Paclitaxel co-treated with Metformin] results in increased expression of CDKN1B mRNA CTD PMID:29309887 palbociclib multiple interactions ISO CDKN1B (Homo sapiens) 6480464 palbociclib promotes the reaction [CCND1 protein binds to CDKN1B protein binds to CDK4 protein] CTD PMID:20473330 palbociclib decreases expression ISO CDKN1B (Homo sapiens) 6480464 palbociclib results in decreased expression of CDKN1B protein CTD PMID:17537993 palbociclib increases expression ISO CDKN1B (Homo sapiens) 6480464 palbociclib results in increased expression of CDKN1B mRNA and palbociclib results in increased expression of CDKN1B protein CTD PMID:17537993 and PMID:20473330 Panduratin A increases expression ISO CDKN1B (Homo sapiens) 6480464 panduratin A results in increased expression of CDKN1B mRNA and panduratin A results in increased expression of CDKN1B protein CTD PMID:16497706 panobinostat increases expression ISO CDKN1B (Homo sapiens) 6480464 panobinostat results in increased expression of CDKN1B protein CTD PMID:18445700 paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of CDKN1B mRNA CTD PMID:16701773 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of CDKN1B mRNA CTD PMID:33387578 Pentoxifylline multiple interactions EXP 6480464 [Pentoxifylline results in increased abundance of Cyclic AMP] which results in increased expression of CDKN1B protein CTD PMID:21693435 perfluorooctane-1-sulfonic acid decreases expression ISO CDKN1B (Homo sapiens) 6480464 perfluorooctane sulfonic acid results in decreased expression of CDKN1B protein CTD PMID:29063134 and PMID:32700164 perfluorooctane-1-sulfonic acid multiple interactions ISO Cdkn1b (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of CDKN1B mRNA CTD PMID:36331819 perfluorooctanoic acid decreases expression ISO CDKN1B (Homo sapiens) 6480464 perfluorooctanoic acid results in decreased expression of CDKN1B protein CTD PMID:29502166 perillyl alcohol increases expression ISO CDKN1B (Homo sapiens) 6480464 perillyl alcohol results in increased expression of CDKN1B protein CTD PMID:17138864 perillyl alcohol increases response to substance ISO CDKN1B (Homo sapiens) 6480464 CDKN1B protein results in increased susceptibility to perillyl alcohol CTD PMID:17138864 perillyl alcohol multiple interactions ISO CDKN1B (Homo sapiens) 6480464 perillyl alcohol promotes the reaction [CDKN1B protein binds to and results in decreased activity of CDK2 protein] CTD PMID:17138864 phenethyl caffeate increases expression EXP 6480464 caffeic acid phenethyl ester results in increased expression of CDKN1B protein CTD PMID:15885897 phenethyl caffeate multiple interactions ISO CDKN1B (Homo sapiens) 6480464 caffeic acid phenethyl ester inhibits the reaction [Folic Acid results in increased expression of CDKN1B protein] CTD PMID:26056802 phenobarbital multiple interactions ISO Cdkn1b (Mus musculus) 6480464 CDKN1B protein inhibits the reaction [[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of CDK2 protein] and CDKN1B results in decreased susceptibility to [Diethylnitrosamine co-treated with Phenobarbital] CTD PMID:17620307 phenylephrine increases expression EXP 6480464 Phenylephrine results in increased expression of CDKN1B CTD PMID:15603588 phorbol 13-acetate 12-myristate decreases expression ISO CDKN1B (Homo sapiens) 6480464 Tetradecanoylphorbol Acetate results in decreased expression of CDKN1B protein CTD PMID:12421932 phorbol 13-acetate 12-myristate multiple interactions ISO Cdkn1b (Mus musculus) 6480464 Tetradecanoylphorbol Acetate inhibits the reaction [taiwanin C results in increased expression of CDKN1B protein] CTD PMID:26537528 phorbol 13-acetate 12-myristate multiple interactions ISO CDKN1B (Homo sapiens) 6480464 Ro 41-5253 inhibits the reaction [Tretinoin promotes the reaction [Tetradecanoylphorbol Acetate results in decreased expression of CDKN1B protein]] and Tretinoin promotes the reaction [Tetradecanoylphorbol Acetate results in decreased expression of CDKN1B protein] CTD PMID:12421932 phosphatidylcholine multiple interactions ISO CDKN1B (Homo sapiens) 6480464 [rubitecan co-treated with Phosphatidylcholines] results in increased expression of CDKN1B protein CTD PMID:21695227 picoxystrobin decreases expression ISO CDKN1B (Homo sapiens) 6480464 picoxystrobin results in decreased expression of CDKN1B mRNA CTD PMID:33512557 pinostrobin increases expression ISO CDKN1B (Homo sapiens) 6480464 pinostrobin results in increased expression of CDKN1B protein CTD PMID:37777166 pioglitazone increases expression ISO CDKN1B (Homo sapiens) 6480464 pioglitazone results in increased expression of CDKN1B protein CTD PMID:26643070 pioglitazone multiple interactions ISO CDKN1B (Homo sapiens) 6480464 pioglitazone inhibits the reaction [[PDGFB protein binds to PDGFB protein] which results in increased degradation of CDKN1B protein] and PRKAA1 protein affects the reaction [pioglitazone results in increased expression of CDKN1B protein] CTD PMID:26643070 pioglitazone multiple interactions EXP 6480464 pioglitazone inhibits the reaction [2-Acetylaminofluorene promotes the reaction [Diethylnitrosamine results in decreased expression of CDKN1B protein]] and pioglitazone promotes the reaction [Diethylnitrosamine results in decreased expression of CDKN1B protein] CTD PMID:17582756 piroxicam multiple interactions EXP 6480464 Piroxicam inhibits the reaction [Azoxymethane results in decreased expression of CDKN1B protein] CTD PMID:12189186 platycodin D increases expression ISO CDKN1B (Homo sapiens) 6480464 platycodin D results in increased expression of CDKN1B protein CTD PMID:25431082 and PMID:27432230 potassium chromate multiple interactions ISO CDKN1B (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of CDKN1B mRNA CTD PMID:22079256 potassium chromate decreases expression ISO CDKN1B (Homo sapiens) 6480464 potassium chromate(VI) results in decreased expression of CDKN1B mRNA CTD PMID:22079256 potassium dichromate increases expression EXP 6480464 Potassium Dichromate results in increased expression of CDKN1B mRNA CTD PMID:26348139 prednisone increases expression ISO CDKN1B (Homo sapiens) 6480464 Prednisone results in increased expression of CDKN1B protein CTD PMID:15034294 progesterone multiple interactions ISO CDKN1B (Homo sapiens) 6480464 [Estradiol co-treated with Progesterone] results in increased expression of CDKN1B mRNA more ... CTD PMID:18850315 more ... progesterone increases expression ISO CDKN1B (Homo sapiens) 6480464 Progesterone results in increased expression of CDKN1B mRNA and Progesterone results in increased expression of CDKN1B protein CTD PMID:18850315 progesterone affects localization ISO CDKN1B (Homo sapiens) 6480464 Progesterone affects the localization of CDKN1B protein CTD PMID:23029392 pterostilbene increases expression ISO CDKN1B (Homo sapiens) 6480464 pterostilbene results in increased expression of CDKN1B protein CTD PMID:23313376 pyrimidines affects splicing ISO CDKN1B (Homo sapiens) 6480464 Pyrimidines affects the splicing of CDKN1B mRNA CTD PMID:25281741 pyrrolidine dithiocarbamate multiple interactions EXP 6480464 pyrrolidine dithiocarbamic acid inhibits the reaction [Allylamine results in increased expression of CDKN1B protein] CTD PMID:15048878 quercetin multiple interactions ISO CDKN1B (Homo sapiens) 6480464 [Cisplatin co-treated with Quercetin] results in increased expression of CDKN1B mRNA more ... CTD PMID:11322924 more ... quercetin increases expression ISO CDKN1B (Homo sapiens) 6480464 Quercetin results in increased expression of CDKN1B protein CTD PMID:11322924 more ... quinazolines affects splicing ISO CDKN1B (Homo sapiens) 6480464 Quinazolines affects the splicing of CDKN1B mRNA CTD PMID:25281741 rac-lactic acid increases expression ISO CDKN1B (Homo sapiens) 6480464 Lactic Acid results in increased expression of CDKN1B mRNA CTD PMID:30851411 raloxifene increases expression ISO CDKN1B (Homo sapiens) 6480464 Raloxifene Hydrochloride results in increased expression of CDKN1B protein CTD PMID:16536755 and PMID:22965848 reserpine multiple interactions EXP 6480464 [troglitazone co-treated with [Hydrochlorothiazide co-treated with Hydralazine co-treated with Reserpine]] results in decreased expression of CDKN1B protein CTD PMID:11318962 resveratrol multiple interactions ISO CDKN1B (Homo sapiens) 6480464 [Plant Extracts co-treated with Resveratrol] results in increased expression of CDKN1B mRNA more ... CTD PMID:17513867 more ... resveratrol decreases expression EXP 6480464 resveratrol results in decreased expression of CDKN1B mRNA CTD PMID:25905778 resveratrol multiple interactions EXP 6480464 resveratrol inhibits the reaction [Glucose results in increased expression of CDKN1B protein] and SIRT1 protein promotes the reaction [resveratrol inhibits the reaction [Glucose results in increased expression of CDKN1B protein]] CTD PMID:22561310 resveratrol increases expression ISO Cdkn1b (Mus musculus) 6480464 resveratrol results in increased expression of CDKN1B protein CTD PMID:21980390 resveratrol increases expression ISO CDKN1B (Homo sapiens) 6480464 resveratrol results in increased expression of CDKN1B mRNA and resveratrol results in increased expression of CDKN1B protein CTD PMID:15829497 more ... rimonabant increases expression ISO CDKN1B (Homo sapiens) 6480464 Rimonabant results in increased expression of CDKN1B protein CTD PMID:16822929 ritonavir increases expression ISO CDKN1B (Homo sapiens) 6480464 Ritonavir results in increased expression of CDKN1B mRNA CTD PMID:19386116 Ro 41-5253 multiple interactions ISO CDKN1B (Homo sapiens) 6480464 Ro 41-5253 inhibits the reaction [Tretinoin promotes the reaction [Tetradecanoylphorbol Acetate results in decreased expression of CDKN1B protein]] CTD PMID:12421932 rubitecan increases expression ISO CDKN1B (Homo sapiens) 6480464 rubitecan results in increased expression of CDKN1B protein CTD PMID:21695227 rubitecan multiple interactions ISO CDKN1B (Homo sapiens) 6480464 [rubitecan co-treated with Phosphatidylcholines] results in increased expression of CDKN1B protein CTD PMID:21695227 S-butyl-DL-homocysteine (S,R)-sulfoximine multiple interactions EXP 6480464 Buthionine Sulfoximine inhibits the reaction [Acetylcysteine results in increased expression of CDKN1B protein] and Buthionine Sulfoximine inhibits the reaction [Curcumin results in increased expression of CDKN1B protein] CTD PMID:17602960 Sanggenon C increases expression ISO CDKN1B (Homo sapiens) 6480464 sanggenone C results in increased expression of CDKN1B protein CTD PMID:37346933 SB 203580 multiple interactions ISO CDKN1B (Homo sapiens) 6480464 SB 203580 inhibits the reaction [[sodium arsenite co-treated with Vitamin K 3] results in increased expression of CDKN1B protein] CTD PMID:19082730 Se-methyl-L-selenocysteine increases expression EXP 6480464 selenomethylselenocysteine results in increased expression of CDKN1B protein CTD PMID:11396176 and PMID:19276161 Se-methylselenocysteine increases expression EXP 6480464 selenomethylselenocysteine results in increased expression of CDKN1B protein CTD PMID:11396176 and PMID:19276161 serpentine asbestos decreases expression ISO Cdkn1b (Mus musculus) 6480464 Asbestos and Serpentine results in decreased expression of CDKN1B mRNA CTD PMID:16251409 silibinin multiple interactions ISO Cdkn1b (Mus musculus) 6480464 Silybin inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CDKN1B protein] CTD PMID:25559859 silibinin increases expression ISO CDKN1B (Homo sapiens) 6480464 Silybin results in increased expression of CDKN1B protein CTD PMID:18435416 silibinin multiple interactions ISO CDKN1B (Homo sapiens) 6480464 [Silybin co-treated with Arsenic] results in increased expression of CDKN1B protein CTD PMID:25868784 silver atom decreases expression ISO Cdkn1b (Mus musculus) 6480464 Silver results in decreased expression of CDKN1B mRNA CTD PMID:27131904 silver(0) decreases expression ISO Cdkn1b (Mus musculus) 6480464 Silver results in decreased expression of CDKN1B mRNA CTD PMID:27131904 simvastatin multiple interactions ISO CDKN1B (Homo sapiens) 6480464 [Simvastatin results in decreased degradation of CDKN1B protein] which results in decreased activity of CDK2 protein CTD PMID:17928568 simvastatin increases expression EXP 6480464 Simvastatin results in increased expression of CDKN1B mRNA and Simvastatin results in increased expression of CDKN1B protein CTD PMID:12963647 and PMID:18804536 simvastatin increases expression ISO CDKN1B (Homo sapiens) 6480464 Simvastatin results in increased expression of CDKN1B mRNA and Simvastatin results in increased expression of CDKN1B protein CTD PMID:17428261 more ... sirolimus multiple interactions ISO CDKN1B (Homo sapiens) 6480464 [Cisplatin inhibits the reaction [[Sirolimus results in increased phosphorylation of AKT1 protein] which results in increased phosphorylation of FOXO3 protein]] which results in increased expression of CDKN1B protein more ... CTD PMID:12417722 more ... sirolimus decreases expression EXP 6480464 Sirolimus results in decreased expression of CDKN1B protein CTD PMID:22561310 sirolimus increases expression ISO CDKN1B (Homo sapiens) 6480464 Sirolimus results in increased expression of CDKN1B protein CTD PMID:15070696 more ... sirolimus multiple interactions EXP 6480464 Niacinamide inhibits the reaction [Sirolimus inhibits the reaction [Glucose results in increased expression of CDKN1B protein]] more ... CTD PMID:19105244 and PMID:22561310 sirolimus multiple interactions ISO Cdkn1b (Mus musculus) 6480464 [Sirolimus co-treated with TGFB1 protein] affects the localization of CDKN1B protein more ... CTD PMID:12417722 and PMID:14979923 sirolimus decreases degradation ISO CDKN1B (Homo sapiens) 6480464 Sirolimus results in decreased degradation of CDKN1B protein CTD PMID:12565877 sirtinol multiple interactions ISO CDKN1B (Homo sapiens) 6480464 sirtinol promotes the reaction [cudraflavone B results in increased expression of CDKN1B protein] CTD PMID:23881456 sodium arsenate increases expression EXP 6480464 sodium arsenate results in increased expression of CDKN1B mRNA and sodium arsenate results in increased expression of CDKN1B protein CTD PMID:14713550 sodium arsenite multiple interactions ISO CDKN1B (Homo sapiens) 6480464 [sodium arsenite co-treated with tetrandrine] results in increased expression of CDKN1B protein more ... CTD PMID:19082730 more ... sodium arsenite decreases expression ISO CDKN1B (Homo sapiens) 6480464 sodium arsenite results in decreased expression of CDKN1B protein CTD PMID:32890875 sodium arsenite increases expression ISO CDKN1B (Homo sapiens) 6480464 sodium arsenite results in increased expression of CDKN1B protein CTD PMID:29039521 and PMID:30123091 sodium arsenite decreases expression ISO Cdkn1b (Mus musculus) 6480464 sodium arsenite results in decreased expression of CDKN1B protein CTD PMID:10764629 sodium arsenite multiple interactions ISO Cdkn1b (Mus musculus) 6480464 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole affects the reaction [[CDKN1B protein affects the susceptibility to [sodium arsenite results in increased abundance of arsenite]] which affects the expression of PTGS2 protein] more ... CTD PMID:20566634 and PMID:23639288 sodium arsenite affects expression ISO CDKN1B (Homo sapiens) 6480464 sodium arsenite affects the expression of CDKN1B mRNA CTD PMID:24535192 sorafenib multiple interactions ISO CDKN1B (Homo sapiens) 6480464 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3 more ... CTD PMID:23036488 sorafenib decreases expression EXP 6480464 sorafenib results in decreased expression of CDKN1B protein CTD PMID:21693435 sorafenib multiple interactions EXP 6480464 sorafenib inhibits the reaction [[Theophylline results in increased abundance of Cyclic AMP] which results in increased expression of CDKN1B protein] CTD PMID:21693435 sorafenib increases expression ISO Cdkn1b (Mus musculus) 6480464 sorafenib results in increased expression of CDKN1B protein CTD PMID:19139124 sorafenib increases expression ISO CDKN1B (Homo sapiens) 6480464 sorafenib results in increased expression of CDKN1B protein CTD PMID:19878585 and PMID:23036488 staurosporine multiple interactions ISO CDKN1B (Homo sapiens) 6480464 Staurosporine inhibits the reaction [Tretinoin results in increased phosphorylation of CDKN1B protein] CTD PMID:16618747 sterigmatocystin decreases expression EXP 6480464 Sterigmatocystin results in decreased expression of CDKN1B mRNA CTD PMID:34126181 stilbenoid increases expression ISO CDKN1B (Homo sapiens) 6480464 Stilbenes analog results in increased expression of CDKN1B mRNA and Stilbenes analog results in increased expression of CDKN1B protein CTD PMID:25980588 sulindac multiple interactions EXP 6480464 Sulindac inhibits the reaction [Azoxymethane results in decreased expression of CDKN1B protein] CTD PMID:12189186 sulindac sulfone increases expression ISO CDKN1B (Homo sapiens) 6480464 sulindac sulfone results in increased expression of CDKN1B mRNA and sulindac sulfone results in increased expression of CDKN1B protein CTD PMID:18593937 tacrolimus hydrate increases expression EXP 6480464 Tacrolimus results in increased expression of CDKN1B mRNA CTD PMID:21865292 taiwanin C increases expression ISO Cdkn1b (Mus musculus) 6480464 taiwanin C results in increased expression of CDKN1B protein CTD PMID:26537528 taiwanin C multiple interactions ISO Cdkn1b (Mus musculus) 6480464 Tetradecanoylphorbol Acetate inhibits the reaction [taiwanin C results in increased expression of CDKN1B protein] CTD PMID:26537528 tamoxifen multiple interactions ISO CDKN1B (Homo sapiens) 6480464 [Tamoxifen co-treated with FTI 277] promotes the reaction [CDKN1B protein binds to [CCNE1 protein binds to CDK2 protein]] and [Tamoxifen co-treated with tipifarnib] results in increased expression of CDKN1B protein CTD PMID:12866041 and PMID:17876043 tamoxifen increases activity ISO CDKN1B (Homo sapiens) 6480464 Tamoxifen results in increased activity of CDKN1B protein CTD PMID:15665275 Tanshinone I multiple interactions ISO Cdkn1b (Mus musculus) 6480464 indirubin promotes the reaction [tanshinone promotes the reaction [tetraarsenic tetrasulfide results in increased expression of CDKN1B protein]] more ... CTD PMID:18344322 Tanshinone I increases expression ISO Cdkn1b (Mus musculus) 6480464 tanshinone results in increased expression of CDKN1B protein CTD PMID:18344322 temozolomide multiple interactions ISO CDKN1B (Homo sapiens) 6480464 [temozolomide co-treated with O(6)-benzylguanine] results in decreased expression of CDKN1B protein CTD PMID:20980775 temozolomide multiple interactions ISO Cdkn1b (Mus musculus) 6480464 [temozolomide co-treated with O(6)-benzylguanine] results in decreased expression of CDKN1B protein CTD PMID:20980775 terazosin increases expression ISO CDKN1B (Homo sapiens) 6480464 Terazosin results in increased expression of CDKN1B protein CTD PMID:12883741 Terfenadine increases expression ISO CDKN1B (Homo sapiens) 6480464 Terfenadine results in increased expression of CDKN1B protein CTD PMID:12244568 tert-butyl hydroperoxide multiple interactions ISO CDKN1B (Homo sapiens) 6480464 [Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of CDKN1B mRNA CTD PMID:35690295 testosterone decreases expression ISO Cdkn1b (Mus musculus) 6480464 Testosterone results in decreased expression of CDKN1B mRNA CTD PMID:15788153 tetrachloromethane decreases expression ISO Cdkn1b (Mus musculus) 6480464 Carbon Tetrachloride results in decreased expression of CDKN1B protein CTD PMID:12759355 tetrachloromethane multiple interactions ISO Cdkn1b (Mus musculus) 6480464 CDKN1B protein affects the reaction [Carbon Tetrachloride results in increased expression of CDKN1A protein] CTD PMID:12759355 theophylline multiple interactions ISO CDKN1B (Homo sapiens) 6480464 [Theophylline results in increased abundance of Cyclic AMP] which results in increased expression of CDKN1B protein CTD PMID:21693435 theophylline multiple interactions EXP 6480464 [Theophylline results in increased abundance of Cyclic AMP] which results in increased expression of CDKN1B protein and sorafenib inhibits the reaction [[Theophylline results in increased abundance of Cyclic AMP] which results in increased expression of CDKN1B protein] CTD PMID:21693435 thioacetamide affects localization EXP 6480464 Thioacetamide affects the localization of CDKN1B protein CTD PMID:22659510 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of CDKN1B mRNA CTD PMID:34492290 thiophenes multiple interactions ISO CDKN1B (Homo sapiens) 6480464 Thiophenes analog promotes the reaction [Tretinoin results in increased expression of CDKN1B protein] CTD PMID:16140954 tipifarnib multiple interactions ISO CDKN1B (Homo sapiens) 6480464 [Tamoxifen co-treated with tipifarnib] results in increased expression of CDKN1B protein CTD PMID:17876043 tolbutamide increases expression EXP 6480464 Tolbutamide results in increased expression of CDKN1B protein CTD PMID:16718685 toluene 2,4-diisocyanate decreases expression ISO Cdkn1b (Mus musculus) 6480464 Toluene 2 and 4-Diisocyanate results in decreased expression of CDKN1B mRNA CTD PMID:21404309 Tomentosin multiple interactions ISO CDKN1B (Homo sapiens) 6480464 Acetylcysteine inhibits the reaction [tomentosin results in increased expression of CDKN1B protein] and FOXO3 protein affects the reaction [tomentosin results in increased expression of CDKN1B protein] CTD PMID:30917517 Tomentosin increases expression ISO CDKN1B (Homo sapiens) 6480464 tomentosin results in increased expression of CDKN1B protein CTD PMID:30917517 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of CDKN1B mRNA CTD PMID:25729387 topotecan decreases expression EXP 6480464 Topotecan results in decreased expression of CDKN1B mRNA CTD PMID:25729387 trans-isoeugenol increases expression ISO CDKN1B (Homo sapiens) 6480464 isoeugenol results in increased expression of CDKN1B protein CTD PMID:22686307 tributylstannane multiple interactions EXP 6480464 [bisphenol A co-treated with tributyltin] results in increased expression of CDKN1B mRNA CTD PMID:31129395 Tributyltin oxide decreases expression EXP 6480464 bis(tri-n-butyltin)oxide results in decreased expression of CDKN1B mRNA CTD PMID:17553608 trichostatin A multiple interactions ISO CDKN1B (Homo sapiens) 6480464 [decitabine co-treated with trichostatin A] results in increased expression of CDKN1B mRNA more ... CTD PMID:17185465 and PMID:17431121 trichostatin A increases expression ISO CDKN1B (Homo sapiens) 6480464 trichostatin A results in increased expression of CDKN1B mRNA and trichostatin A results in increased expression of CDKN1B protein CTD PMID:17431121 and PMID:23770000 trichostatin A affects expression ISO CDKN1B (Homo sapiens) 6480464 [trichostatin A affects the expression of DNMT3B protein] which affects the expression of CDKN1B mRNA CTD PMID:18544619 Triptolide increases expression EXP 6480464 triptolide results in increased expression of CDKN1B protein CTD PMID:32519852 troglitazone multiple interactions ISO CDKN1B (Homo sapiens) 6480464 [troglitazone binds to and results in increased activity of PPARG protein] which results in decreased degradation of CDKN1B protein more ... CTD PMID:11034103 more ... troglitazone increases expression ISO CDKN1B (Homo sapiens) 6480464 troglitazone results in increased expression of CDKN1B mRNA and troglitazone results in increased expression of CDKN1B protein CTD PMID:11343236 more ... troglitazone affects response to substance ISO CDKN1B (Homo sapiens) 6480464 CDKN1B protein affects the susceptibility to troglitazone CTD PMID:11034103 troglitazone decreases expression EXP 6480464 troglitazone results in decreased expression of CDKN1B protein CTD PMID:11318962 troglitazone multiple interactions EXP 6480464 [troglitazone co-treated with [Hydrochlorothiazide co-treated with Hydralazine co-treated with Reserpine]] results in decreased expression of CDKN1B protein CTD PMID:11318962 troglitazone decreases expression ISO CDKN1B (Homo sapiens) 6480464 troglitazone results in decreased expression of CDKN1B mRNA and troglitazone results in decreased expression of CDKN1B protein CTD PMID:12680223 urethane decreases expression ISO Cdkn1b (Mus musculus) 6480464 Urethane results in decreased expression of CDKN1B mRNA CTD PMID:12117781 ursolic acid increases expression ISO CDKN1B (Homo sapiens) 6480464 Ursolic Acid results in increased expression of CDKN1B protein CTD PMID:24802810 valproic acid multiple interactions ISO CDKN1B (Homo sapiens) 6480464 [Valproic Acid co-treated with Hydroxyurea] results in increased expression of CDKN1B mRNA more ... CTD PMID:17653085 and PMID:21737646 valproic acid affects expression ISO CDKN1B (Homo sapiens) 6480464 Valproic Acid affects the expression of CDKN1B mRNA CTD PMID:25979313 valproic acid decreases expression ISO CDKN1B (Homo sapiens) 6480464 Valproic Acid results in decreased expression of CDKN1B mRNA CTD PMID:23179753 and PMID:28001369 valproic acid increases expression ISO Cdkn1b (Mus musculus) 6480464 Valproic Acid results in increased expression of CDKN1B protein CTD PMID:21708246 valproic acid increases expression ISO CDKN1B (Homo sapiens) 6480464 Valproic Acid results in increased expression of CDKN1B protein CTD PMID:21737646 valsartan multiple interactions ISO CDKN1B (Homo sapiens) 6480464 Valsartan inhibits the reaction [AGT protein results in decreased expression of CDKN1B mRNA] CTD PMID:19225232 vemurafenib multiple interactions ISO CDKN1B (Homo sapiens) 6480464 [(+)-JQ1 compound co-treated with vemurafenib] results in increased expression of CDKN1B protein CTD PMID:27169980 vinyl carbamate multiple interactions ISO Cdkn1b (Mus musculus) 6480464 Budesonide inhibits the reaction [vinyl carbamate results in decreased expression of CDKN1B protein] CTD PMID:12117777 vinyl carbamate decreases expression ISO Cdkn1b (Mus musculus) 6480464 vinyl carbamate results in decreased expression of CDKN1B protein CTD PMID:12117777 vitamin E increases expression ISO CDKN1B (Homo sapiens) 6480464 Vitamin E results in increased expression of CDKN1B protein CTD PMID:12352461 vorinostat multiple interactions ISO CDKN1B (Homo sapiens) 6480464 [Bortezomib co-treated with Vorinostat] results in increased cleavage of CDKN1B protein more ... CTD PMID:12446442 more ... vorinostat increases expression ISO CDKN1B (Homo sapiens) 6480464 vorinostat results in increased expression of CDKN1B mRNA and vorinostat results in increased expression of CDKN1B protein CTD PMID:12446442 more ... wogonin increases expression ISO CDKN1B (Homo sapiens) 6480464 wogonin results in increased expression of CDKN1B protein CTD PMID:23872260 wogonin increases expression EXP 6480464 wogonin results in increased expression of CDKN1B protein CTD PMID:23872260 wortmannin multiple interactions ISO CDKN1B (Homo sapiens) 6480464 wortmannin promotes the reaction [Doxorubicin results in increased expression of CDKN1B protein] and wortmannin promotes the reaction [Etoposide results in increased expression of CDKN1B protein] CTD PMID:17935137 wortmannin increases expression ISO Cdkn1b (Mus musculus) 6480464 wortmannin results in increased expression of CDKN1B protein CTD PMID:17129604 wortmannin multiple interactions ISO Cdkn1b (Mus musculus) 6480464 Imatinib Mesylate promotes the reaction [wortmannin results in increased expression of CDKN1B protein] CTD PMID:17129604 Y-27632 increases expression EXP 6480464 Y 27632 results in increased expression of CDKN1B mRNA CTD PMID:20578043 zidovudine multiple interactions ISO CDKN1B (Homo sapiens) 6480464 [Zidovudine co-treated with Lamivudine] results in decreased expression of CDKN1B mRNA CTD PMID:15784690 zinc acetate multiple interactions ISO CDKN1B (Homo sapiens) 6480464 [Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of CDKN1B mRNA CTD PMID:16357179 zinc acetate increases expression ISO CDKN1B (Homo sapiens) 6480464 Zinc Acetate results in increased expression of CDKN1B mRNA CTD PMID:16357179 zinc dichloride decreases expression ISO CDKN1B (Homo sapiens) 6480464 zinc chloride results in decreased expression of CDKN1B mRNA CTD PMID:21540303 zoledronic acid multiple interactions ISO CDKN1B (Homo sapiens) 6480464 [Zoledronic Acid co-treated with 4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide] results in decreased expression of CDKN1B protein more ... CTD PMID:16322342 and PMID:19530242